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ABSTRACT 
 The development of small-molecules which target nucleic acids, more specifically the 
minor groove of DNA, in a sequence specific manner and control gene expression are currently 
being investigated as potential therapeutic compounds for the treatment of various diseases, 
including cancer, as well as viral and bacterial infections.  The naturally occurring compounds 
netropsin and distamycin have been shown to demonstrate antitumor and antibacterial properties.  
Currently, there are synthetic efforts to create pyrrole and imidazole-containing polyamide 
derivatives of netropsin and distamycin that show potential as medicinal agents.  Synthetic 
pyrrole and imidazole-containing polyamides are potentially useful for targeting and modulating 
the expression of genes, including those associated with cancer cell growth.  
 The key challenges that must be overcome to realize this goal of using synthetic 
polyamides in the treatment of disease are the development of polyamides with low molar mass 
so the molecules can readily diffuse into cells and concentrate in the nucleus. In addition, the 
molecules must have appreciable water solubility, bind DNA sequence specifically, and with 
high affinity. As part of a systematic study within the authors’ laboratory, our goal is to develop 
polyamides which can be synthesized readily yet possess excellent sequence specificity, stronger 
binding affinity, high solubility in biological media and enhanced cell penetration and nuclear 
localization properties. 
 There is a need to develop a library of modified polyamides which target DNA and 
exhibit improved biological properties.  The present study is a systematic examination of the 
binding properties of various modified synthetic polyamide compounds. The synthetic 
polyamide derivatives presented have more potential as therapeutic candidates over other 
synthetic polyamides because of their increased water solubility, smaller molecular weights,  and 
molecular design, thus, allowing them to penetrate into cells and localize in the nucleus.  
 
INDEX WORDS:  DNA, minor groove, polyamides, netropsin, distamycin, imidazole, pyrrole,  
sequence specificity, gene control, surface plasmon resonance, isothermal 
titration calorimetry 
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CHAPTER 1:  
AN INTRODUCTION TO AND HISTORY OF POLYAMIDES: NETROPSIN AND 
DISTAMYCIN, NATURALLY OCCURING POLYAMIDES THAT TARGET THE 
MINOR GROOVE OF DNA IN A SEQUENCE SPECIFIC MANNER AND 
DEMONSTRATE BIOLOGICAL ACTIVITY 
  
2 
 
1.1 Discovery of netropsin and distamycin 
Netropsin is a naturally occurring oligopeptide first discovered and isolated by Finlay et 
al. in 1951 (1).  This oligopeptide has been of significant interest over the last sixty years 
because of its biological activity. Netropsin has shown both antibacterial and antiviral activity 
and is classified as a pyrrole (Py)-containing amide antibiotic, although it is not used clinically 
because of toxicity.  It was isolated from the actinobacterium Streptomyces netropsis and given 
the name “netropsin” (1).  Netropsin small molecules consist of two pyrrole rings and two 
terminal amidine groups linked together by amide (peptide) bonds, as shown in Figure 1A. 
Distamycin is also a naturally occurring oligopeptide discovered in 1958 by Arcamone et 
al. and isolated from an actinomycete bacterium, Streptomyces distallcius, of the same 
Streptomyces genus as netropsin.  Distamycin was discovered as a byproduct from the 
fermentation of S. distallcius. Distamycin, like netropsin, has demonstrated antiviral and 
antibiotic properties, as well as antitumor characteristics.  Distamycin is very similar in structure 
to netropsin although it does have an additional pyrrole ring, thus, being comprised of three 
pyrrole (Py) rings, each connected by a peptide bond, one terminal amidine (instead of two like 
netropsin), and a terminal formamido (f) group, as shown in Figure 1B.  Distamycin is classified 
as a pyrrole-containing amidine antibiotic but is also not used clinically due to its cytotoxicity.  
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Figure 1.  Chemical structure of the polyamide netropsin (A) and distamycin (B). 
 
 
1.2 Polyamides as DNA minor groove binders 
 
The major groove of DNA is most often the binding site for protein-DNA interactions. 
This is due to the diversity and accessibility of the functional groups of the base pairs to protein 
structures.  However, this is not usually the case with small molecules, such as netropsin and 
distamycin which bind to the minor groove. The two grooves differ in electrostatic potential, 
hydration, hydrogen bonding, and steric properties (2).  Moreover, they also have very different 
microstructures and conformations which are highly dependent upon base pair composition.  For 
example, long consecutive runs of adenosine bases are known to exhibit a very narrow minor 
groove when compared to the minor groove of a stretch DNA that consists of guanine and 
cytosine base pairs (2).  It is through these differences that the minor groove has become an 
attractive target for small molecules. Polyamide small molecules, such as netropsin and 
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distamycin, preferentially bind to the minor groove of DNA in a sequence specific manner.  It 
has been shown that netropsin and distamycin preferentially bind to AT-rich sequences.  The 
narrower minor groove enhances electrostatic interactions between the small molecule and the 
minor groove.   
 Netropsin and distamycin are comprised of multiple simple aromatic ring systems, linked 
together by bonds which have torsional freedom.  The torsional freedom of these bonds allows 
them to adopt a crescent shape which is a typical, yet a key structural property of minor groove 
binding (2).  The torsional freedom and crescent shape adopted by the small molecule allows it 
to twist in such a way that it becomes isohelical with the DNA minor groove.  Because the 
polyamide and DNA are isohelical, contacts between the two are optimized (2). 
 The narrowness of AT-rich minor groove sequences allow for the optimal van der Waals 
interactions between the crescently shaped polyamide and the helical chains that define the walls 
of the minor groove.  Additionally, hydrogen bonding between bound ligands and the base pairs 
found at the floor of the minor groove creates both sequence specificity and stability of the 
complex.  A-T base pairs are able to accept hydrogen bonds from the small molecule through the 
C2-carbonyl oxygen of thymine and the N3 nitrogen of adenine.  Although there are similar 
functional groups found on C-G bases, the exocyclic amine at the N3 position of guanine and the 
exocyclic oxygen at the O2 position of cytosine form a hydrogen bond and create a steric 
hindrance, and thus, the small molecules netropsin and distamycin bind specifically to AT-rich 
sequences.  The hydrogen bond between the amine group of guanine and the carbonyl oxygen of 
cytosine extends into the minor groove also, adding to the steric hindrance and not allowing 
penetration in to the minor groove by netropsin or distamycin (3).  It has also been shown that 
the electrostatic potential of the minor groove of AT-rich DNA sequences is much greater than 
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that of the minor groove of GC-rich DNA sequences, therefore, the favorable binding to AT-rich 
sequences by positively charged small molecules, such as netropsin and distamycin, is favorable. 
The ability of the exocyclic amine to become a hydrogen bond donor can be exploited for 
sequence recognition and enhanced binding affinity by modified polyamides.  This concept will 
be addressed in section 1.4.  
 
Figure 2.  X-ray crystallographic structure of 1:1 netropsin-DNA complex (4).  
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 The first crystal structure of a netropsin-DNA complex with 5’-(dCGCGAATTCGCG)2-
3’  was solved by Dickerson et al. in 1985 (5).  The complex showed a single netropsin molecule 
bound to the AATT-site, as was expected.  The three amide –NH groups point towards the floor 
of the minor groove forming bifurcated hydrogen bonds with the O2 of thymine and N3 of 
adenine, as shown in Figure 2.  van der Waals contacts are formed between the tightly bound 
polyamide and the atoms which comprise the sugar-phosphate walls of the groove, creating a 
parallel plane between the pyrrole rings of netropsin and the walls of the groove.  The interaction 
of the two cationic amidine groups and the N3 of the 5’ adenine is favorable and a key 
component of complex formation.  The methyl groups at the N5 position of the pyrrole rings 
point into the solution, resulting in an ability for the compound to penetrate into the minor 
groove. 
  The crystal structure for distamycin has several key features very similar to that of 
netropsin.  However, an NMR study by Wemmer et al. in 1990 showed distamycin bound as a 
stacked homodimer to the sequence 5’-CGCGAAATTTCGCG-3’(Figure 3) (3, 6-8).  The 
additional two base pairs (compared to the AATT site) in the central recognition site allowed for 
the “longer” distamycin molecule and could accommodate the stacked dimer even in the 
narrower AT-rich minor groove.  Data from this study showed that the 2:1 distamycin-DNA 
complex was favored for binding sites six base pairs or longer, and the 1:1 complex for a binding 
site of four base pairs (5’-AATT-3’).  
 Two distamycin molecules bind to the minor groove of DNA in the same fashion as 
netropsin.  The amide hydrogens of the distamycin molecules face towards the floor of the minor 
groove, forming bifurcated hydrogen bonds with the O2 of thymine and N3 of adenine.  The two 
ligands stack in a “staggered” manner in which the two positive charges of the amidine groups 
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are at opposite ends (antiparallel), thus maximizing the distance between the charges and 
reducing the electrostatic repulsion.  Because netropsin has two positive charges on the terminal 
amidine groups, one on each end, the electrostatic repulsion would be too great for netropsin to 
bind as a homodimer and this explains why the observed stoichiometry of netropsin-DNA 
complexation is 1:1 and not 2:1.  In order to accommodate the two distamycin molecules, the 
minor groove must widen.  The structural change as a result of 2:1 distamycin-DNA 
complexation causes a positive, unfavorable overall free energy contribution.  Although the 
widening of the groove is unfavorable, it is compensated by a highly favorable hydrophobic 
interaction that is a direct result of stacking and binding two ligands within one binding site of 
the minor groove. 
  
 
Figure 3.  NMR structure of 2:1 distamycin-DNA complex (4).  
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1.3 Netropsin and distamycin interactions: A look at energetics 
 
The thermodynamic and binding properties of both netropsin and distamycin to DNA 
have been studied extensively.  Because of advancements in instrumentation over the last twenty 
years, enthalpic and entropic contributions to the overall free energy have been measured, giving 
a more complete thermodynamic profile and defining the driving force behind complexation.  
The 2:1 binding of distamycin to 5’-AAATT-3’ compared to the 1:1 complex formation of 
netropsin and 5’-AAATT-3’ have been examined and compared (9).  Both netropsin and 
distamycin have favorable binding enthalpy contributions and are exothermic processes.  Drug 
binding is most often associated with a favorable enthalpic binding process (2, 3).  The enthalpy 
for netropsin binding to 5’-AAATT-3’ is ~-31 kJ/mol.  The enthalpy for binding two distamycin 
molecules to the same DNA sequence are ~-52 kJ/mol for the first molecule and ~79 kJ/mol for 
the second (2).  Keq for netropsin is ~108 M-1 (10) and K1 and K2 for distamycin are ~107 M-1 and 
106 M-1, respectively.  Because K2 is ~10 times less than K1, the binding of two distamycin 
molecules to one binding site is a negatively cooperative process for five AT base pairs. 
The binding process for netropsin and the first distamycin compound are very similar in 
nature.  Both have similar binding affinities and are both enthalpically driven, although binding 
of the first distamycin molecule has a larger enthalpic contribution.  Both polyamides have very 
similar hydrogen bonding patterns which could explain why the binding enthalpies are similar 
for both complexes.  The presence of an additional cationic group for netropsin compared to 
distamycin allows for more favorable electrostatic interactions for netropsin.  However, 
distamycin has an additional pyrrole ring which allows for more favorable hydrophobic 
interactions, and thus compensates for the decrease in electrostatic interactions.  Although the 
enthalpies of binding for netropsin and distamycin are very similar, the entropic contributions to 
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the overall Gibbs free energy are opposite for the two polyamides.  Netropsin has a favorable 
entropy whereas distamycin has an unfavorable entropy.  The differences in entropy are 
attributed to changes in hydration; water is released or taken up upon binding, and the release of 
counter ions. 
 
1.4 Synthetic derivatives of netropsin and distamycin 
Since their discovery sixty years ago, netropsin and distamycin have served as templates 
for the design of synthetic polyamides.  In the mid-late 1980’s, Lown (11) and Dickerson et al. 
(12), developed synthetic polyamides, lexitropsins, which could target G-C and C-G sequences 
(13). This was accomplished by substituting an N-methyl pyrrole (Py) with an N-methyl 
imidazole (Im).  The additional nitrogen in the imidazole ring acts as a hydrogen bond acceptor 
and can hydrogen bond with the exocyclic amino group of guanine.  Targeting of G-C and C-G 
sequences through the use of Im rings developed by Lown and Dickerson were exploited by 
Dervan, who eventually developed a set of binding rules which are outlined in Figure 4 (14-18).  
Figure 4 shows a schematic view of binding the synthetic polyamide Im-Py-Py to the sequence 
5’-TGTCA-3’ (4).  In theory, this concept allowed for the programmable targeting of any 
specific DNA sequence.  The idea of programmably targeting specific DNA sequences led to an 
explosion in synthetic efforts of numerous laboratories throughout the scientific community.  
The two differences between netropsin and distamycin are: 1) netropsin has two pyrrole 
rings and distamycin has three, and 2) netropsin has two positively charged termini groups and 
distamycin has one cationic amidine terminus and a formamido (f) group at the other terminus.  
Most synthetic efforts have left off the terminal formamido group because of synthetic 
difficulties (19).  The influence of the terminal formamido on stacking and binding was formally 
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addressed and studied by Lacy et al. in 2001 (20).  The addition of a terminal formamido led to a 
staggered, antiparallel stacking formation and a 10-100 fold increase in binding affinity 
depending on the synthetic polyamide.  This systematic study revealed the importance of the 
terminal formamido group and its influence on the mode of stacking, which directly impacts the 
binding affinity and kinetics of complexation (20).  The study also showed the presence of a 
terminal formamido group had no advantage in terms of sequence specificity. 
 
 
Figure 4.  Schematic representation of G-C recognition of Im-Py and the binding of Im-Py-Py to 
5’-TGTCA-3’. The dashed lines represent hydrogen bonds between the synthetic polyamide and 
its recognition sequence (4).  The black circles of the inset signify Im rings, the open circles Py 
rings and the crescent shape + are the positively charged tail region. 
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From the development of Dervan’s pairing rules, numerous different types of polyamides 
have been developed to optimize both binding affinity and sequence specificity.  Upon the 
discovery of the 2:1 complex formation of distamycin with 5’-AAATTT-3’ through Wemmer’s 
NMR structure, synthetic developments have been made to covalently link the two dimers.  This 
led to the development of hairpin polyamides, where two polyamides are linked from the 3’ 
terminus (end) of one to the 5’ terminus (tail) of the other, H-pin polyamides, where two 
polyamides are linked via N5 position of both central Py or Im rings, and cyclic polyamides, 
where two polyamides are linked from both the 5’ and 3’ ends to the opposing 3’ and 5’ ends of 
the second polyamide molecule.  The lengths of the linking moieties have been well studied for 
all three polyamide derivatives, as have the addition of functional groups on the linkers (21-24). 
1.5 Polyamides control gene expression: potential as therapeutics to treat various 
diseases 
 
Since their discovery and isolation, netropsin and distamycin have been known to have 
biological activity as antibiotic, antiviral and antitumor therapeutics, leading to the hypothesis 
that these two molecules are synthesized naturally by streptomycete strains as a potential defense 
mechanism (3).  Though too toxic for clinical use, these compounds have been used to elucidate 
the origins of sequence specificity and biological activity.  These molecules are thought to 
interfere with topoisomerase in some fashion, although their true mechanism is not completely 
understood.  Excitingly, synthetic Py- and Im-containing polyamides have not shown the same 
levels of toxicity as netropsin and distamycin. 
 The first publication to report the biological activity of a synthetic polyamide in vivo was 
by Gottesfeld in Nature in 1997 (25).  The authors reported the activity of a hairpin polyamide, 
ImPyPyPy-γ-ImPyPyPy-β-Dp, where γ represents the γ-aminobutyric acid linker, β represents 
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the (CH2)3 alkyl linker which links the terminal secondary amine and the last pyrrole ring.  This 
synthetic hairpin polyamide binds to the sequence 5’-TAGTACT-3’, which is found within the 
promoter site of the TFIIA gene, and causes inhibition of the 5S RNA through direct 
competition.  In vivo studies showed the presence of the hairpin polyamide led to a reduction in 
5S RNA by interfering with the transcriptional process of the TFIIA gene.  Although a debate 
remains about the viability of larger hairpin polyamides and their ability to permeate into the 
cells and localize in the nucleus, Gottesfeld et al. presented a strong first argument for the use of 
polyamides as therapeutics showing direct evidence addressing these issues (3, 25). 
 Modulation of gene expression, specifically the inverted 5’-CCAAT-3’ of the 
topoisomerase IIα (topoIIα) gene, through the use of polyamide-DNA interactions has been of 
interest in the Lee laboratory (26).  TopoIIα plays a role in many cell processes, including DNA 
replication and mitosis, and is a target of the anticancer drugs etoposide and doxorubicin (27-29).  
TopoIIα is down regulated in confluent cancer cells, and thus, these cells become resistant to 
treatment using the anticancer agents etoposide and doxorubicin.  The nuclear factor-Y (NF-Y) 
protein is responsible for inhibition of gene expression at confluence. NF-Y binds to the inverted 
CCAAT-box 2 (ICB2, there are 5 total in the promoter region).  Polyamide binding to ICB2 
blocks the site and NF-Y cannot bind to it, leading to the upregulation of topoIIα expression and 
making them susceptible to treatment with etoposide and doxorubicin (26, 30).  Lee’s laboratory 
has shown that the synthetic polyamide f-PyImPy  binds to the sequence 5’-TACGAT-3’ which 
flanks the ICB2 binding site and inhibits the binding of NF-Y (26). 
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1.6 Objectives of this Dissertation 
Although synthetic polyamides have shown promise as potential therapeutics, there is 
still a need to understand the fundamentals of their biological activity.  Modification and 
modulation of gene expression by small molecules is still not completely understood.  There has 
to be a fundamental understanding of how modifying synthetic polyamides affects polyamide-
DNA complex formation, in terms of sequence specificity and binding affinity.  This dissertation 
presents five publications which systematically characterize the effects of synthetically modified 
polyamides on binding affinity and sequence selectivity. 
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CHAPTER 2: 
DNA RECOGNITION: DESIGN, SYNTHESIS AND BIOPHYSICAL 
CHARACTERISTICS OF PYRROLE (H) BASED POLYAMIDES 
 
 
The work presented in this chapter is based on the published paper “DNA Recognition: Design, 
Synthesis and Biophysical Characteristics of Pyrrole(H) based Polyamides.” from Medicinal 
Chemistry, 2010, 6, 150-158.  Synthetic methods and write ups are attributed to Dr. Moses Lee 
of Hope College and various members of the Lee Research Group. Dr. John Hartley from the UK 
Drug-DNA Interactions Research Group is credited with the DNase I footprinting work and 
writings. My contribution to this paper was the SPR experiments, data analyses and writings, 
along with Dr. Manoj Munde and Dr. W. David Wilson. 
 
  
18 
 
DNA Recognition: Design, Synthesis and Biophysical 
Characteristics of Pyrrole(H) based Polyamides. 
 
Sameer Chavdaa, Keith Muldera, Toni Browna, Hilary Mackaya, Balaji Babua, Laura Westratea, 
Amanda Fergusona, Shicai Linc, Konstantinos Kiakosc, Joseph P. Ramosb, Manoj Mundeb, W. 
David Wilsonb, John A. Hartleyc and Moses Leea,  
 
aDepartment of Chemistry and the Division of Natural and Applied Sciences, Hope College 
49423, USA 
bDepartment of Chemistry, Georgia State University Atlanta, GA, 30303, USA  
cCancer Research, UK Drug-DNA Interactions Research Group, UCL Cancer Institute, Paul O’ 
Gorman Building, 72 Huntley Street, London WCIE 6BT, UK 
 
 
 
 
 
 
 
 
 
 
19 
 
2.1 Abstract 
N-Methyl imidazole (Im) and N-methyl pyrrole (Py)-containing polyamides that can form 
stacked dimers can be programmed to target specific DNA sequences in the minor groove of 
DNA and control gene expression. Polyamides are being investigated as potential medicinal 
agents for treating diseases including cancer. The naturally occurring polyamide distamycin 
binds as a dimer in the minor groove of DNA and recognizes sequences rich in A/T and T/A base 
pairs indiscriminately. Synthetic analogs of distamycin that incorporate N-methylimidazole into 
the heterocyclic core have been shown to bind to G/C rich sequences with a high degree of 
specificity. The purpose of this study is to investigate the behavior of polyamides containing the 
2, 5-linked N-methylpyrrole-2-carboxamide or pyrrole(H) [Py(H)] moiety upon binding to DNA. 
The synthesis and biophysical characteristics of two polyamides PyPyPyPy(H) 2 and 
ImPyPyPy(H) 3 designed to test the binding preference of a Py/Pyrrole(H) pairing [Py/Py(H)] 
and a [Im/Py(H)] is described. Studies utilizing circular dichroism, thermal denaturation (∆TM), 
biosensor-surface plasmon resonance and DNase I footprinting show that an [Im/Py(H), 3] 
pairing prefers a G/C or C/G pairing whilst a [Py/Py(H), 2] pairing tolerates A/T or T/A base 
pairs and avoids a G/C base pair. 
    
Keywords: polyamides, pyrrole(H), DNA, sequence specificity, minor groove binder
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2.2 Introduction  
The development of polyamide analogs of distamycin 1 (Figure 2.1) that can target 
specific DNA sequences is a fascinating and well documented area of research. Such compounds 
exhibit potential for use as gene regulatory agents by inhibiting the binding of native 
transcription factors at the target promoter site, and are being investigated as potential medicinal 
agents for treating diseases including cancer [1]. The pyrrole (Py) heterocyclic moieties in 
distamycin stack as a 2:1 antiparallel dimer in the DNA minor groove and can bind 
indiscriminately to an A/T or a T/A base pair [2a-d]. Alternatively, an imidazole (Im) 
heterocycle moiety can be paired opposite a pyrrole to selectively target a G/C base pair [2d]. In 
addition, 3-hydroxy-1H-pyrrole (Hp) has been paired opposite Py and shown to selectively target 
T/A base pairs but with a significant loss in binding affinity. This could possibly attribute to a 
handful of factors ranging from sterics to chemical instability [3a-c]. The bulky hydroxyl group 
on an Hp containing polyamide (which forms an additional hydrogen bond to the O-2 group of 
thymine), makes the 2:1 complex formed in the minor groove sterically encumbered leading to 
unfavorable binding. Accordingly the additional hydrogen bonding to thymine O-2 could be 
critical for distinguishing A/T from T/A. We envisaged that a polyamide containing a reversed 
conformation Py moiety [Py(H) or 2,5-linked N-methylpyrrole-2-carboxamide] stacked over a 
polyamide containing Py [Py(H)/Py] may recognize a T/A base pair. In addition, it has been 
reported that the N-H group on this Py(H) moiety should form a more favorable van der Waals 
distance with thymine thus resulting in enhanced binding affinity [4]. In an attempt to test this 
hypothesis, we chose to synthesize two polyamides PyPyPyPy(H)-N-dimethyl-3-
aminopropylamine 2 and ImPyPyPy(H)-N-dimethyl-3-aminopropylamine 3 (Figure 1). We chose 
to incorporate only one Py(H) moiety into each of these polyamides as previous studies have 
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shown that incorporation of multiple 2,5-linked [3a] or 2,4-linked Py(H) [4a] units may result in 
a loss in sequence specificity, thus allowing for an increased tolerance of G/C base recognition 
[4a]. Even though polyamides bind DNA effectively through the 2:1 stacked motif, they are also 
known to bind in a 1:1 fashion within the minor groove of DNA [4b]. 
2.3 Results and Discussion    
2.3.1 Polyamide and DNA sequence design  
Two tetraheterocyclic polyamides (tetraamides) 2 and 3 were synthesized to study the 
binding preference for stacked Py(H)/heterocycle pairings (Figure 2.2). These tetraamides 
contain one of two different terminal pairing motifs: –ImPy– and –PyPy–, which are the best 
pyrrole and imidazole containing terminal pairings in terms of binding affinity to Watson and 
Crick sequences [3d]. Two of the DNA sequences tested for these studies (AT_10 and TA_10) 
were designed such that the specificity of a Py/Py-H for a TA base pair could be assessed 
relative to that for an AT base pair. In addition, we were also interested to ascertain whether a 
stacked Py-H/Im would exhibit any selectivity for CG or GC base pairs to potentially uncover 
any new pairing rules. In addition, two additional sequences CG_10 and GC_10 (Figure 2) were 
included in the study. The binding of 2 and 3 against the 10 base pair sequences ACGCGT 
(Figure 2) was also undertaken. This sequence is of significant interest for drug design and 
discovery due to its G/C richness and presence in the core sequence of the Mlul cell-cycle box 
(MCB) transcriptional element indirectly implicated in the development of various cancers [5, 6, 
7].  
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2.3.2 Synthesis 
The synthetic approach towards obtaining polyamides 2 and 3 is outlined in Scheme 2.1. 
Nitration of 4 furnished 4-nitro-2-trichloroacetylpyrrole 5 in good yield, which in turn, was 
coupled with commercially available N,N-dimethyl-3-aminopropylamine in the presence 
triethylamine to furnish the monoheterocyclic component 6 [8]. This was followed by 
subsequent reduction of 6 using standard palladium catalyzed hydrogenation [9] to the resulting 
amino derivative (not shown) followed by immediate coupling to 4-nitro-1-methylpyrrole-2-
carbonyl chloride 7 (formed from the corresponding carboxylic acid). The resulting diamide 
(O2N-PyPy(H)-N-dimethyl-3-aminopropylamine, 8), formed in 22% yield was, in turn, coupled 
to another molecule of 4-nitro-1-methylpyrrole-2-carbonyl chloride 7 using the protocol 
described, to furnish the corresponding triamide (O2N-PyPyPy(H)-tail 9 in 39% yield (Scheme 
2.1).  At this point, we attempted to couple the relevant terminal heterocycle by forming the acid 
chloride of the relevant commercially available carboxylic acid (10, Scheme 2.1) and coupling 
this with the reduced amine form (Schotten-Baumann coupling) of 9 (formed by palladium 
catalyzed reduction in methanol) to give the final tetraamide 2 in 28% yield (Scheme 2.1). 
However, this did not seem to be the case for the formation of the tetraamide 3 due to low yields. 
An alternative set of coupling conditions utilizing the lithium salt 11 of imidazole-2-carboxylic 
acid [10] with benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBop) 
and N,N-diisopropyl-N-ethylamine (DiPEA) in dry DCM (Scheme 2.1), furnished tetraamide 3 in 
an improved yield. In general, one of the reasons for the low yields of these tetraamides and their 
tri- and diamide precursors, can be attributed to the instability of the amine intermediates [11] as 
well as the reactivity of the pyrrole and imidazole acid chlorides.  
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2.3.3 Thermal melting studies 
Thermal melting studies were conducted to determine whether polyamides 2 and 3 
stabilize duplex DNA at elevated temperatures. The data shown in Table 1 indicates that 
polyamide 2 can only produce a ∆TM value of 3°C for the AT_10 sequence. TA_10, CG_10 and 
GC_10 did not increase the melting temperature in the presence of tetraamide 2. On the other 
hand polyamide 3 exhibits some stabilization on sequences AT_10, TA_10 and GC_10 giving 
∆TM values of 2, 2 and 3°C, respectively but did not induce a ∆TM for CG_10. 
2.3.4 Circular dichroism studies 
Circular dichroism studies (the ability of chiral molecules to absorb circularly polarized 
light: the DNA/polyamide complex is chiral due to the DNA’s inherent chirality) were 
performed on PyPyPyPy(H)-N-dimethyl-3-aminopropylamine 2 and 3 ImPyPyPy(H)-N-
dimethyl-3-aminopropylamine on the same DNA sequences used in the thermal denaturation 
studies (Figure 3). The results shown in Figure 2.3 for 3 confirm that it binds within the floor of 
the minor groove of the DNAs tested due to the appearance of an induced band at 330 nm [12]. 
The results also indicate that polyamide 2 gave weaker induced CD bands than 3 when titrated 
into solutions of the DNAs mentioned. Except for AT_10, the results were in agreement with the 
thermal denaturation data shown in Table 2.1. However, as depicted in Figure 3 polyamide 2 
produced clear DNA induced ligand bands when titrated into solutions of AT_10 and TA_10 
suggesting a limited preference of Py/Py(H) for an AT or TA base pair. The most impressive 
result was achieved when polyamide 3 was titrated into a solution of GC_10 with near-saturation 
being achieved after addition of two equivalents of 3, further corroborated by a ∆TM value of 3 
°C. In addition, the appearance of a clear isodichroic point provides evidence that binding is 
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occurring via a single motif characteristic of a typical DNA minor groove binder. It is interesting 
to note that, though a ∆TM value of 0°C was observed for polyamide 3 when titrated into a 
solution of CG_10 (Table 2.1), a significant amount of binding is observed in the CD study 
(Figure 3) in turn, suggesting binding of 3 to this DNA sequence is possibly thermodynamically 
less favorable than when binding to GC_10.  
2.3.5 DNase I footprinting 
DNase I footprinting experiments were performed on 2 and 3 using a 131 bp 5`-[32P]-
radiolabelled DNA fragment containing the following sequences: (a) 5`-AAATTT-`3; AT_10 (b) 
5`-ATATAT-`3; TA_10 (c) 5`-ACATGT-`3; CG_10 (d) 5`-AGATCT-`3; GC_10 and (d) 5`-
AGAGCT-`3. Autoradiogram A (Figure 2.4) shows that polyamide 2 exhibits good sequence 
specificity mostly for TA_10 DNA. A clear footprint appears at 20 µM, which is consistent with 
CD and ∆TM measurements (Table 2.1 and Figure 2.3). Polyamide 2 also displays negligible 
binding to GC_10 as shown by the appearance of a weak footprint at 100 µM. In comparison, 3 
seems to show better binding affinity towards the sequences tested but poorer sequence 
selectivity. Autoradiogram B (Figure 2.4) shows that for polyamide 3, footprints at 5’-ATATAT-
3’, 5`-AGATCT-`3 and 5`-ACATGT-`3 are evident at 6 µM. This is corroborated by the thermal 
melting and CD data (Figure 2.3 and Table 2.1). In addition, enhanced cleavage appears to occur 
at the locations close to the AT_10 site. Enhanced cleavage sites have been reported for binding 
of polyamides to DNA [13].  
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2.3.6 Surface Plasmon Resonance 
To obtain a more accurate measure of binding affinity, selectivity and to probe the 
stoichiometry of binding, SPR-biosensor experiments were performed. As described in the 
Methods Section, the biotin-labeled GC_10, AT_10 and TA_10 DNA hairpin duplexes were 
immobilized by streptavidin capture in three of the four flow cells. The fourth was left blank and 
used as a control. Compounds 2 and 3 were then injected over the DNA and blank flow cells at a 
range of concentrations. From the sensorgrams in Figure 2.5, it can be observed that 3 shows 
good selectivity for GC_10. The kinetics are relatively fast and all of the sensorgrams reach a 
steady state plateau below 200 s.  Binding constants were determined by plotting the steady state 
RU values, determined by averaging over a 10 s time period in the steady state region, versus the 
compound concentration and fitting with either a one or two site binding model (Methods 
Section). Compound 3 binds strongly to GC_10 (K= 2 × 106 M-1, Table 2.1) with 2:1 
stoichiometry but shows weaker binding towards AT_10 by 10-fold (K= 2 × 105 M-1) with the 
data best fitting a 1:1 stoichiometry.  Very weak binding was observed for 3 with TA_10 and the 
stoichiometry could not be determined. Binding constants were determined by the same 
procedure for the pyrrole compound, 2. It also has fast kinetics and shows selectivity for AT base 
pair sequences. Compound 2 shows significantly stronger binding to AT_10 than to TA_10 with 
the best fit to a 1:1 binding model in both cases (Table 2.1) and shows very weak binding to 
GC_10.  
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2.4 Conclusion 
Overall, this study has shown that, polyamide 2 containing the Py/Py(H) pairing, displays 
weaker binding than expected to its cognate sequences. The results do show sequence selectivity 
(towards AT_10), in agreement with its predicted specificity, but with a lack of marked binding 
affinity. However, it prefers to avoid a G/C base pair, as ascertained by SPR, DNase I 
footprinting and thermal melting techniques. On the other hand, 3, which contains an Im/Py(H) 
pairing, prefers a G/C or C/G base pair. For these reasons, we believe that additional polyamides 
related to 2 and 3 are worthy of further investigation. 
2.4.1 Experimental 
Solvents and organic reagents were purchased from Aldrich or Fisher, and in most cases were 
used without further purification. DCM (P2O5), and DMF (BaO) were distilled prior to use. 
Melting points (mp) were performed using a Mel-temp instrument and are uncorrected. Infrared 
(IR) spectra were recorded using a FT-IR instrument as films on NaCl discs. 1H-NMR spectra 
were obtained using a Varian Unity Inova 400 instrument. Chemical shifts (δ) are reported at 20 
°C in parts per million (ppm) downfield using tetramethylsilane (Me4Si) as an internal standard. 
High-resolution mass spectra (HRMS) and low-resolution mass spectra (LRMS) were provided 
by the Mass Spectrometry Laboratory, University of South Carolina, Columbia. Reaction 
progress was assessed by thin-layer chromatography (TLC) using Merck silica gel (60 F254) on 
aluminum plates unless otherwise stated. Visualization was achieved with UV light at 254 nm 
and/or 366 nm, I2 vapor staining and ninhydrin spray. 
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2.4.2 Synthesis 
2-Trichloroacetylpyrrole 4 and 5-nitro-2-trichloroacetylpyrrole 5 
These precursor compounds were synthesized according to a literature protocol and were 
spectroscopically identical to those reported [3]. 
O2N-Py(H) N,N-dimethyl-3-aminopropylamine 6 
O2N-Py(H)-CCl3 (500 mg, 1.95 mmol) was dissolved in dry CH2Cl2 (60 mL) and triethylamine 
(0.41 mL, 2.93 mmol), N,N-dimethyl-3-aminopropylamine (0.37 mL, 2.93 mmol) was added and 
the reaction mixture was heated at reflux for ~18 h. The reaction was quenched with water (50 
ml) and the resulting aqueous basified to pH 10 was and the organic layer was collected. The 
aqueous was extracted with CHCl2 (2 × 40 mL). The combined organic layers were dried over 
Na2SO4 and evaporated to dryness. The crude product was purified using flash chromatography 
on silica gel eluting with to yield 6 as an orange/yellow solid (300 mg, 68%); RF 0.46 (silica gel, 
40:39.5:0.5 MeOH:CHCl3:NH4OH); mp 154-160 ºC;  υ (cm-1) 1692 (C=O); δH (400 MHz; 
CDCl3) 7.65 (1 H, d, J 1.6 Hz); 7.15 (1 H, d, J 1.6), 3.37 (2 H, t, J 6.8), 2.49 (2 H, t, J 6.8); 2.34 
(6 H, s) and 1.76 (2 H, quintet, J 6.8); LRMS: (direct probe) m/z (rel. intensity) 240 ([M+], 5%), 
139 (4%), 93 (4%), 72 (5%). 
O2N-Py-Py(H) N,N-dimethyl-3-aminopropylamine 8 
A round bottom flask purged with argon, containing O2N-Py(H)-N-dimethyl-3-
aminopropylamine, 6 (186 mg, 0.82 mmol), 5% Pd/C (93 mg, 50% by wt.) cold MeOH (60 ml) 
was cautiously added and the resulting solution was stirred under H2 for 12 h. The Pd/C catalyst 
was filtered over a pad of celite and the filtrate co-evaporated with CHCl2 (3 × 20 mL) to give a 
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yellow/brown oil which was stored under high vacuum out of light. NO2-Py-COOH (0.168 g, 
0.987 mmol) was dissolved in SOCl2 (3 mL) and refluxed for 15 minutes. The resulting solution 
was co-evaporated with CHCl2 (3 × 15 mL) to give the acid chloride 7 as an oil which was 
diluted with dry CH2Cl2 (5 mL) and added dropwise to a stirring solution of the reduced form of 
6 and dry triethylamine (0.14 ml, 0.99 mmol) in dry CHCl2 (10 mL) cold (0 ºC, ice/water). The 
reaction mixture was stirred at room temperature overnight. A basic aqueous work-up was 
performed and the organic layers collected, dried over (Na2SO4) and evaporated to dryness. The 
crude product was purified using flash-column chromatography to yield 8 as a yellow solid (67 
mg, 22%), mp. decomposition at 200 ºC; RF 0.20 (silica gel, 80:19.5:0.5 % v/v; 
CHCl3:MeOH:NH4OH); υ (CH2Cl2, cm-1) 1640 (C=O) 1636 (C=O); δH (400 MHz, CDCl3) 10.08 
(1 H, s (br), 9.24 (1 H, s (br)), 7.74 (1 H, s (br)), 7.59 ( 1 H, d, J 1.6), 7.37 (1 H, s), 7.36 (1 H, d, 
J 1.6), 6.70 (1 H, s), 4.02 (3 H, s), 3.42 (2 H, t, J  6.4), 2.44 (2 H, t, J 6.4), 2.30 (6 H, s) and 1.76 
(2 H, quintet, J 6.4); MS: (ES+) m/z (rel. intensity) 363 ([M+H] 100%), 255 (5%). 
O2N-Py-Py-Py(H) N,N-dimethyl-3-aminopropylamine 9 
In the same way as for 8, O2N-Py-Py(H)-N-dimethyl-3-aminopropylamine 8 (67 mg, 0.184 
mmol), 5% Pd/C (35 mg, 50% by wt.) and cold MeOH (40 mL) gave the corresponding amine as 
a yellow oil. Also in the same way as 8, NO2-Py-COCl 7 (from NO2-Py-COOH, 37 mg, 0.22 
mmol and 3) and dry triethylamine (0.03 ml, 0.22 mmol) gave  crude 9 which was purified using 
flash chromatography eluting in to yield 9 as a yellow/brown solid (35 mg, 39%); mp 
decomposition at 200 ºC: RF 0.3 (silica gel, 60:39.5:0.5 CHCl3:MeOH:NH4OH); υ (CH2Cl2, cm-
1) 1640 (C=O) 1636 (C=O), 1638 (C=O); δH (400 MHz, CDCl3) 7.57 (1 H, d, J  2.0); 7.35 (1 H, 
d, J 1.6), 7.33 (1 H, d, J 1.6); 7.24 (1 H, d, J 1.6), 6.77 (1 H, J 1.6), 6.72 (1 H, d, J  1.6); 3.99 (3 
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H, s), 3.90 (3 H, s), 3.39 ( 2 H, t, J 6.4), 2.63 (2 H, t, J 7.2); 2.45 (6 H, s) and 1.83 (2 H, quintet, J 
7.2); LRMS: (ES+) m/z (rel. intensity) 485 ([M+H], 100%), 377 (20%). 
Py-Py-Py-Py(H) N,N-dimethyl-3-aminopropylamine 2 
In the same way as for the method stated in for the reduction of 8 and coupling of the resultant 
amine, O2N-Py-Py-Py(H)-N-dimethyl-3-aminopropylamine 9 (75 mg, 0.155 mmol), 5% Pd/C 
(40 mg, 50% by wt) and cold MeOH (8 mL) gave the resultant amine as a orange/yellow oil. The 
amine from 11, Py-COCl 10 (from 39 mg, 0.309 mmol) pyrrole-2-carboxylic acid and dry 
triethylamine (0.04 mL, 0.30 mmol) gave a crude product was purified using flash 
chromatography to yield 2 as an orange solid (25 mg, 28%), mp decomposition at 210 ºC; RF 
0.30 (silica gel, 60:39.5:0.5 CHCl3/MeOH/NH4OH); 1640 (C=O) 1636 (C=O), 1638 (C=O) and 
1637 (C=O); δH (400 MHz, CDCl3) 7.77 (1 H, d, J 2.0); 7.52 (1 H, d, J 1.6), 7.33 (1 H, d, J 1.6); 
7.23 ( 1 H, d, J 1.6), 7.12 (1 H, s),  6.77 (2 H, d, J 1.6), 6.10 (1 H, d, J =1.6), 6.09 (1 H, d, J 1.6), 
5.55 (2 H, 2 × s (br)), 5.15 (2 H, 2 × s (br)), 3.93 (3 H, s), 3.90 (3 H, s), 3.89 (3 H, s), 3.35 ( 2 H, 
t, J 7.2), 2.63 (2 H, t, J 7.2); 2.55 (6 H, s) and 1.85 (2 H, quintet, J 7.2); LRMS: 562 ([M+H], 
100%), 282 (80%), 145 (90%); HRMS: C28H36N9O4 requires 562.2890; found 562.2901. 
Im-Py-Py-Py(H) N,N-dimethyl-3-aminopropylamine 3 
The reduction of 9 was achieved by following the same protocol as stated in for 8 using the 
following: O2N-Py-Py-Py(H)-tail 9 (75 mg, 0.155 mmol), 5%Pd/C (40 mg, 50% by wt.) and cold 
MeOH (65 mL). The lithiated salt of 1 methylimidazole-2-carboxylic acid 11, from 39 mg, 0.309 
mmol 1-methylimidazole-2 carboxylic acid) and PyBOP (39 mg, 0.309 mmol) were dissolved in 
dry DCM (10 mL) under argon. DiPEA (0.084 mL, 0.33 mmol) was added to the solution and 
the reaction mixture was stirred at 50 ºC for 3 days. A basic aqueous work-up was performed 
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(similar to that of described previously and the organic layer collected, dried over (Na2SO4) and 
evaporated to dryness. The crude product was purified using flash-column chromatography to 
yield 3 as a yellow solid (15 mg, 17%), mp. decomposition at 210 ºC; RF 0.40 (silica gel, 
60:39.5:0.5 CHCl3:MeOH:NH4OH); υ (neat, cm-1) 1640 (C=O) 1636 (C=O), 1638 (C=O) and 
1635 (C=O); δH (400 MHz, CDCl3); 10.32 (1 H, s (br)), 9.45 (1 H, s (br)), 8.48 (1 H, s (br), 8.27 
(1 H, s (br)) 7.89 (1 H, s (br)), 7.34 (1 H, d, J 2.4), 7.21 (1 H, d, J 2.4), 7.00 (1 H, t, J 4.8), 6.94 
(1 H, s), 6.79 (1 H, s), 6.68 (1 H, d, J 6.5), 6.65 (1 H, d, J 6.5), 4.03 (3 H, s), 3.88 (3 H, s,), 3.38 
(3 H, s), 3.40 (2 H, t, J 7.2), 2.45 (2 H, t, J 7.2), 2.21 (6 H, 2 × s) and  1.71-1.63 (2 H, quintet, J 
7.2); LRMS: (ES+) m/z (rel. intensity) 563 ([M+H], 15%), 297 (45%), 282 (100%), 145 (20%); 
HRMS, C27H35N10O4 requires 563.2842; found C27H35N10O4 563.2847. 
2.4.3 Biophysical 
All buffer reagents were obtained from Sigma-Aldrich or Fisher, and used without further 
purification unless stated otherwise. The synthetic oligonucleotides were obtained from Operon 
(Huntsville, AL): ACGCGT (5'-ACGCGT-3'): 5'-GA ACGCGT CG CTCT CGACGCGTTC-3'; 
A3T3_10 (5'-A3T3-3'): 5'-CG AAATTT CC CTCT GG AAATTT CG-3'; AT_10 (5'-AT-3'): 5'-
CC AAATTT CC CTCTGG AAATTT GG; TA_10 (5'-TA-3'): 5'-CC ATATAT CC CTCTGG 
ATATAT GG; CG_10 (5'-CG-3'); 5'-CC ACATGT CC CTCTGG ACATGT GG and GC_10 
(5'-GC-3'); 5'-CC AGATCT CC CTCTGG AGATCT GG were used in the thermal denaturation 
and circular dichroism experiments without further purification. DNA used in the footprinting 
and SPR experiments are described below. CD data was obtained using an Olis DSM20 
instrument. ∆TM data were obtained using a Varian-Cary 100 Biomelt UV–visible 
spectrophotometer, equipped with a Peltier temperature controller and a precision cuvette-
mounted temperature probe. Phosphate buffer: PO40 (10 mM sodium phosphate, 1mM EDTA, 
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pH 6.4) was used for CD and Tm experiments. All data were analyzed using KaleidaGraph 
(Snergy Software, Reading PA), unless otherwise stated. Ligand stock solutions were prepared in 
double distilled water at a concentration of 0.5 mM, unless otherwise specified. 
2.4.4 Circular dichroism (CD) 
CD studies were performed using previously reported procedures [14b,f] and were 
conducted at ambient temperature in a 1-mm path length quartz cell using PO4 buffer.  Buffer 
and stock DNA were added to the cuvette to give a final DNA concentration of 9 µM.  Each 
polyamide (in 500µL in double distilled) H2O was titrated in 1 molar equivalents into the 
relevant DNA (160 µL of 9 µM DNA) until saturation was achieved.  Each run was performed 
over 400-220 nm. The CD response at the λmax of the induced peak was plotted against the mole 
ratio of ligand:DNA. 
2.4.5 Thermal denaturation (∆TM) 
Thermal denaturation studies were performed using published procedures [3d]. 
Experiments for polyamides 2 and 3 were performed at a concentration of 3 µM ligand and 1 µM 
DNA. All experiments were run in PO4 buffer. Oligonucleotide samples were reannealed prior to 
denaturation studies by heating at 70 ºC for 1 min then cooling to RT. Heating runs were 
typically performed between 25 and 95 ºC, with a heating rate of 0.5 ºC min–1, while 
continuously monitoring the absorbance at 260 nm (digitally sampled at 200 ms intervals). All 
melts were performed in 10-mm path length quartz cells. Tm values were determined as the 
maximum of the first derivative. 
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2.4.6 Surface plasmon resonance (SPR) 
Buffers: a 0.01 M cacodylic acid (CCA) solution pH 6.25 contained 0.001 M EDTA 
(disodium ethylenediamine tetraacetate), 0.1 M NaCl and 0.005% (by vol.) surfactant P20 which 
was (Biacore AB) used to reduce the nonspecific binding of polyamides to the fluidics and 
sensor chip surface. In addition, a 0.01 M HEPES (N-[2-Hydroxyethyl]piperazine-N’-[2-
ethanesulfonic acid]) solution pH 7.4 containing 0.15 M NaCl, 0.003 M EDTA and 0.005% (by 
volume) surfactant P20 was used during the DNA immobilization process. All buffers were 
degassed and filtered prior to experiments.  DNA sequences were obtained from Integrated DNA 
Technologies (San Diego, CA) with HPLC purification and were used without further purifying. 
The lyophilized 5’ biotin-labeled DNA hairpin constructs were dissolved in the appropriate 
amount of DI H2O to create 1.0 mM DNA stock solutions.  Further dilutions were made using 
0.01 M HEPES buffer during the DNA immobilization step. DNA concentrations were 
determined spectrophotometrically using extinction coefficients calculated for each individual 
DNA sequence by using the nearest neighboring for singled stranded DNA method. Stock 
solutions of 4 and 5 were prepared by dissolving the solid compound in the necessary amount of 
distilled H2O to create a stock solution with a concentration of approximately 1.0 x 10-3 M. Stock 
solutions were kept frozen at 4 ˚C until experimental use to minimize any degradation of the 
compound. Samples for SPR experiments were prepared by a series of dilutions from the stock 
solution using a 0.01 M cacodylic acid buffer solution. 
The surface plasmon resonance (SPR) experiments were conducted to analyze real time 
interactions between the polyamide compounds and specific DNA sequences. All SPR 
experiments were conducted using a four flow cell Biacore 2000 biosensor instrument (GE Life 
Sciences). DNA hairpin constructs labeled with biotin at the 5’ end were immobilized onto a 
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streptavidin-coated sensor chip (BIAsensorSA) as previously reported [14]. The 5’-biotin-labeled 
DNA hairpins were immobilized on three of the four flow cells. The fourth was left blank and 
used as a control.  All SPR experiments were performed at 25 ˚C and used 0.01 M CCA as the 
running buffer. The amount of DNA immobilized was approximately 400 response units (RU). 
This was achieved by continuously injecting ~ 20 µL of an approximately 50 nM DNA solution 
at a rate of 2 µL/min onto the sensor chip surface until a relative response of 400 units was 
reached.  Binding data was obtained by injecting known concentrations and were analyzed with 
one or two site binding models as previously described [14]. 
2.4.7 DNase I Footprinting Studies  
The designed DNA fragment was amplified by using PCR as follows. The forward 
primer 5’- GTCGGTTAGGAGAGCTCCACTTG-3’ (4 pmol) was 5’ 32P end-labeled with [-32P] 
ATP using T4 kinase (Invitrogen) following standard protocols.  PCR amplification was 
performed in a reaction mixture of 50 µL containing the 32P labeled primer, 4 pmol of reverse 
primer 5’-CTCCAGAAAGCCGGCACTCAG-3’, 2 µL of 25 mM MgCl2, 2.5 µL of 2.5 mM 
dNTPs (Promega, UK), 1U Flexi GoTaq polymerase (Promega,UK), the supplied 5x GoTaq 
buffer, and 0.125 pmol  of each of the templates 
5’ATGCTCCAGAAAGCCGGCACTCAGTCTACAAAAATTTCATCTTGATCATATATGTT
CACAGAGCTCTCTCTAGATCTAGATCTAACTCTAGTACATGTCTTCAAGCAAGTGGA
GCTCTCCTAACCGACTTT-3′ and 
5′-AAAGTCGGTTAGGAGAGCTCCACTTGCTTGAAGACATGTACTAGAGTTA 
GATCTAGATCTAGAGAGAGCTCTGTGAACATATATGATCAAGATGAAATTTTTGTAG
ACTGAGTGCCGGCTTTCTGGAGCAT-3’.  
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PCR cycling conditions consisted of an initial denaturation step for 3 min at 95 °C, and 1 min at 
94 °C, 1 min at 63 °C, and 1 min at 72 °C for a total of 35 cycles. The amplified fragment was 
isolated on a 2% agarose gel electrophoresis and purified with the Mermaid Kit (Q-biogene) 
according to the manufacturer’s instructions.   
DNase I digestions were conducted in a total volume of 8 µL. The labeled DNA fragment 
(2 µL, 200 counts s-1) was incubated for 30min at room temperature in 4 µL TN binding buffer 
(10 mM Tris Base, 10 mM NaCl, pH 7) containing the required drug concentration.  Cleavage by 
DNase I was initiated by addition of 2 µL of DNase I solution (20 mM NaCl, 2 mM MgCl2, 2 
mM MnCl2, DNase I 0.02U, pH 8.0) and stopped after 3 min by snap freezing the samples on dry 
ice. The samples were subsequently lyophilized to dryness and resuspended in 5 µL of 
formamide loading dye (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% 
cyanol blue). Following heat denaturation for 5 min at 90oC, the samples were loaded on a 
denaturing polyacrylamide (10%) gel (Sequagel, National Diagnostics, UK) containing urea (7.5 
mM). Electrophoresis was carried out for 2 hours at 1650 V (~70W, 50°C) in 1X TBE buffer. 
The gel was then transferred onto Whatman 3MM and dried under vacuum at 80°C for 2 h. The 
gel was exposed overnight to medical X-Ray film (Super RX, Fuji) and developed on a Konica 
Medical Film Processor SRX-101A, 
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Figure 2.1 Structures of Distamycin 1, synthesized polyamides 2 and 3 designed to differentiate 
between A and T base pairs: PyPyPyPy(H)-N,N-dimethyl-3-aminopropylamine 2 and 
ImPyPyPy(H) )-N,N-dimethyl-3-aminopropylamine 3. 
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AT_10; 5'-AT-3': 5'-CG AAATTT CC CTCT GG AAATTT CG-3'  
TA_10; 5'-TA-3': 5'-CC ATATAT CC CTCTGG ATATAT GG- 3'  
CG_10; 5'-CG-3'; 5'-CC ACATGT CC CTCTGG ACATGT GG-3'  
GC_10; 5'-GC-3'; 5'-CC AGATCT CC CTCTGG AGATCT GG-3'  
ACGCGT; 5'-ACGCGT-3': 5'-GA ACGCGT CG CTCT CGACGCGTTC-3' 
 
 
Figure 2.2 Binding of 2 and 3 to DNA in a 2:1 motif along with the 10 base pair DNA sequences 
to test any new pairing rules. 
 
 
  
5`- A/T               A/T      A/T     A/T    T/A               A/T
3`- A/T              A/T      A/T     A/T     T/A               
5` - A/T             C/G     A/T     A/T   G/C               A/T 
3`- A/T              C/G     A/T     A/T    C/G               
4
5
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Figure 2.3 Circular dichroism data for 2 and 3. Note that the horizontal axis represents 
wavelength (nm) whilst the CD in millidegrees (mdeg) is represented on the vertical axis. Both 
polyamides 2 and 3 (each in 500µL in double distilled H2O) were titrated in 1 molar equivalents 
into the relevant DNA (160 µL of 9 µM DNA) until saturation was achieved. 
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A (PA2)     B (PA3) 
  
 
Figure 2.4 DNase I footprinting data of polyamides 2 (A) and 3 (B). 
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Figure 2.5 SPR sensorgrams of 3 with the sequence AGATCT, GC_10 (A), 3 with AT_10 (B), 2 with 
AT_10 (C).  The ligand concentrations on the sensorgrams from the lowest to highest response are 0.1, 
0.2, 0.3, 0.5, 0.7, 0.9, 1, 1.3, 1.5, 1.7, 2, 2.3, 2.5, 2.7, 3, 3.5, 4, 4.5 and 5 µM.  All sensorgrams were 
plotted on the same scale and concentration range for comparison.  
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Scheme 2.1 Synthesis of 2 and 3. Reagents and conditions: (i) ClCOCCl3, CH2Cl2; (ii) Ac2O; 
HNO3; (iii) Et3N, N,N-dimethyl-3-aminopropylamine, dry DCM, reflux, ~ 18 h; (iv) 5% Pd/C, 
cold MeOH, H2, RT, ~ 12 h then Et3N, dry DCM, acid chloride 7; 0 °C-RT 12 hrs; (v) 5% Pd/C, 
cold MeOH, H2, RT~ 12 h, ; dry Et3N, dry DCM, reduced amine from 8, 0-25 ºC, ~ 12 h. 
Synthesis of 2: (vi) 5% Pd/C, cold MeOH, H2, RT, ~ 18 h then 10, dry Et3N, dry DCM, 0 °C then 
warm to RT, stir 12 hrs. Synthesis of  5; (iiv) 5% Pd/C, cold MeOH, H2, RT, ~ 18 h then 11, 
PyBOP, dry DCM, DiPEA, RT-50 ºC, 3 days. 
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Table 2.1 Thermal denaturation data for polyamides 2 and 3 and binding constants for 
polyamides 2 and 3 (as ascertained from SPR) for the sequences TA_10, GC_10 and A3T3_10. 
 
 
Polyamide 
 
AT_10 
 
TA_10 
Sequence 
GC_10 
 
CG_10 
 
ACGCGT 
      
(∆TM) PyPyPyPy(H)-N-
dimethyl-3-
aminopropylamine 2 
  
  3ºC    0ºC       0ºC   0ºC 0ºC 
     Ka (polyamide 2) 
(M-1) 
 
1 × 106 <1 × 105 <<1 × 105 ND ND 
(∆TM) ImPyPyPy(H)- N-
dimethyl-3-
aminopropylamine 3 
  
1ºC 2ºC 3ºC 0ºC 0ºC 
Ka (polyamide 3) 
(M-1) 
2 × 105 <1 × 105 2 × 106 ND ND 
   
   
ND-not determined 
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CHAPTER 3: 
SYNTHESIS AND DNA BINDING PROPERTIES OF 1-(3-
AMINOPROPYL)IMIDAZOLE-CONTAINING TRIAMIDE f-Im*PyIm: A NOVEL 
DIAMINO POLYAMIDE DESIGNED TO TARGET 5’-ACGCGT-3’ 
 
 
 
The work presented in this chapter is based on the published paper “Synthesis and DNA Binding 
Properties of 1-(3-aminopropyl)Imidazole-Containing Triamide f-Im*PyIm: A Novel Diamino 
Polyamide Designed to Target 5’-ACGCGT-3’”from Bioorganic & Medicinal Chemistry Letters, 
2012, accepted May 1, 2012, In press.  Synthetic methods and write ups are attributed to Dr. 
Moses Lee of Hope College and various members of the Lee Research Group. Dr. John Hartley 
from the UK Drug-DNA Interactions Research Group is credited with the DNase I footprinting 
work and writings. My contribution to this paper was the SPR and ITC experiments, data 
analyses and writings, along with Dr. Yang Liu and Dr. W. David Wilson. 
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3.1 Abstract 
 A novel diamino/dicationic polyamide f-Im*PyIm (5) that contains an orthogonally 
positioned aminopropyl chain on an imidazole (Im*) moiety was designed to target 5’-
ACGCGT-3’. The DNA binding properties of the diamino polyamide 5, determined by CD, 
∆TM, DNase I footprinting, SPR, and ITC studies, were compared with those of its 
monoamino/monocationic counterpart f-ImPyIm (1) and its diamino/dicationic isomer f-
ImPy*Im (2), which has the aminopropyl group attached to the central pyrrole unit (Py*). The 
results gave evidence for the minor groove binding and selectivity of polyamide 5 for the 
cognate sequence 5’-ACGCGT-3’, and with strong affinity (Keq = 2.3 x 107 M-1). However, the 
binding affinities varied according to the order: f-ImPy*Im (2) > f-ImPyIm (1) ≥ f-Im*PyIm (5) 
confirming that the second amino group can improve affinity, but that its position within the 
polyamide can affect affinity. 
 
Keywords: polyamides, diamino, dicationic, 5’ACGCGT-3’, MluI cell cycle, MCB 
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3.2  Introduction 
 Pyrrole and imidazole-containing analogs of distamycin are polyamides that bind in the 
minor groove of DNA at specific DNA sequences in a stacked fashion.1 They are potentially 
useful for targeting and modulating the expression of genes, including those associated with 
cancer cell growth.2–4 Formamido(f)-Imidazole(Im)-Pyrrole(Py)-Imidazole(Im) (1, Figure 3.1) is 
such a monoamino or monocationic polyamide (PA) molecule that binds selectively as a 2:1 
(polyamide:DNA) stacked dimer in the minor-groove of 5’-ACGCGT-3’. The binding affinity is 
1.9 × 108 M-1.5-8 The 5’-ACGCGT-3’ sequence is significant because it occurs in the core 
segment of the Mlu1 cell-cycle box (MCB) transcriptional element found in the promoter of the 
human Dbf4 (huDbf4 or ASK, activator of S-phase kinase) gene. Dbf4 is the regulatory subunit 
of Cdc7 (cyclin dependent 7) kinase, and high levels of this kinase have been implicated for the 
development of various cancers.9 
Despite demonstrating excellent in-vitro activity10, the development of polyamides has 
been stymied by limited solubility and cellular uptake;11 although several positive results from 
in-vivo experiments have been reported.12 Our laboratories are responding to these challenges by 
focusing efforts on designing and testing novel polyamides that contain orthogonally positioned 
diamino groups. Our strategy involves functionalizing the polyamides by incorporating an 
additional aminoalkyl group at the N-position of the pyrroles or imidazoles. We hypothesized 
that diamino polyamides would display the following properties: enhanced binding affinity, 
solubility in aqueous biological media, cell penetration, nuclear localization, and at least 
maintains the sequence specificity. The inspiration of this work was derived from reports 
showing that polyamides containing a pyrrole–N-alkyl spermine/spermidine group targeted A/T 
rich sequences and bound with high affinity.13  
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Figure 3.1 Structures of the monoamino polyamide f-ImPyIm (1), an orthogonally positioned 
diamino polyamide f-ImPy*Im (2), the non-formamido polyamides, diamino Ph-ImPy*Im (3) 
and monoamino Ph-ImPyIm (4), and a diamino polyamide f-Im*PyIm (5). Py* and Im* 
represent the N-(3-aminopropyl)pyrrole and 1-(3-aminopropyl)imidazole moieties, respectively. 
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Scheme 3.1 Reagents and conditions: (i) oxalyl chloride, dry THF, reflux, 45 min; (ii) dry 
triethylamine, dry DCM, rt, 18 h; (iii) H2, 5% Pd/C, methanol, rt, 18 h; (iv) acetic formic 
anhydride, rt, 18 h; (iv) dry ammonia, dry methanol, 60 °C, 16 h. 
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3.3  Experimental 
3.3.1  Synthesis 
The target diamino/dicationic polyamide f-Im*PyIm 5 was synthesized according to the 
approach depicted in Scheme 1. 1-(3-Chloropropyl)-4-nitroimidazole-2-carboxylic acid 616 and 
oxalyl chloride were refluxed in dry THF for 45 min and the acid chloride was coupled with 
freshly prepared amine 75-8,17 in dry dichloromethane at room temperature. The nitro-triamide 
compound 8, obtained in 36% yield, was hydrogenated over Pd-C (5%) in methanol at room 
temperature to yield the corresponding amine, which in turn was treated with acetic formic 
anhydride to afford formamido-triamide 9 in 65% yield. SN2 displacement of the chloride in 9 
with dry ammonia in methanol at 60 °C furnished the desired diamino/dicationic f-Im*PyIm 
polyamide 5 in 28% yield.18 
3.3.2  DNase I footprinting studies 
With f-Im*PyIm (5) in hand, its DNA binding properties were examined. DNase I 
footprinting studies were performed using a 132 bp 5’-[32P]-radiolabeled engineered DNA 
fragment containing the DNA sequences 5’-ACGCGT-3’, 5’-ACCGGT-3’, 5’-ACACGT-3’ and 
5’-AGCGCT-3’. The results depicted in Figure 3.2A provided direct evidence of footprinting at 
5’-ACGCGT-3’ emerging at 0.05 µM and becoming clearly evident at 0.10 µM. In contrast, no 
footprint at the three other sites was apparent until about 1 µM when some binding began to 
appear at 5’-AGCGCT-3’. In contrast, at 1 µM, both f-ImPyIm5 and f-ImPy*Im14 showed clear 
footprints at 5’-AGCGCT-3’ and 5’ACACGT-3’. These results demonstrated a somewhat 
enhanced sequence specificity of f-Im*PyIm (5) for its cognate sequence over its parent 
molecule f-ImPyIm (1) and its isomer f-ImPy*Im (2). As summarized in Table 3.1, the onset of a 
footprint at 5’-ACGCGT-3’ for f-Im*PyIm (0.05-0.10 µM) was slightly higher than that for its 
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parent molecule f-ImPyIm and its isomer f-ImPy*Im (both at 0.050 µM), suggesting possibly a 
slightly reduced binding affinity. 
3.3.3  Thermal denaturation studies 
Thermal denaturation experiments were performed to further examine the sequence 
selectivity of polyamide 5 using the following DNA sequences: 5’-ACGCGT-3’, 5’-AAATTT-3’ 
(5’-A3T3-3’) and 5’-ATGCAT-3’. The ∆TM values given in Table 3.1 were determined from the 
difference in melting temperatures of the DNA-polyamide complex and duplex DNA alone. In 
each case, 1.0 µM of DNA and 3.0 µM of polyamide were used. Comparable to its isomer f-
ImPy*Im (2), the diamino polyamide f-Im*PyIm (5) showed remarkable interaction with its 
cognate sequence 5’-ACGCGT-3’ as evidenced by ∆TM values >20 °C.14 Not surprisingly, the 
∆TM values for their non-cognate sequences were lower, particularly 5’-AAATTT-3’. These 
results offered evidence that a diamino polyamide that contain an aminopropyl chain attached to 
the 1-position of imidazole or pyrrole is able to stabilize the DNA significantly greater than its 
parent f-ImPyIm (1), which gave a ∆TM of 7.8 °C for the cognate sequence 5’-ACGCGT-3’.5 
3.3.4  Circular dichroism studies 
CD spectroscopy was used to probe the binding of f-Im*PyIm (5) in the minor groove of 
double-stranded DNA. These experiments were conducted by titrating each polyamide with 
DNA solutions comprised of the DNA sequences tested in the thermal denaturation studies. As 
demonstrated in Figure 3.2B, the diamino polyamide 5 bound effectively to its cognate sequence 
5’-ACGCGT-3’. The presence of a strong and positive induced CD band at ~330 nm in CD 
spectra is typical of minor grove binding by polyamides.5-8,14,15 The distinct isodichroic point at 
~310 nm suggested that 5 was bound to the DNA by a single mechanism, presumably by binding 
in the minor groove as a stacked dimer. This binding mode is similar to that reported for the 
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binding of f-ImPy*Im (2)14 and the parent monoamino polyamide 15 to the cognate sequence 5’-
ACGCGT-3’. These results indicate that the presence of a second positively charged group in the 
form of an orthogonally positioned alkylammonium side chain and its position either on an 
imidazole or pyrrole heterocycle does not significantly affect sequence selectivity nor does it 
affect the conformation of the ligand-DNA complex in any significant way.  
3.3.5  SPR studies 
The biosensor method, SPR, has emerged as a powerful tool for measuring the binding 
constants of small molecules to synthetic oligonucleotides.5-8,14,15,19 The target diamino molecule 
f-Im*PyIm (5) was tested against three oligonucleotides: the cognate sequence 5’-ACGCGT-3’, 
and two non-cognate sequences 5’-ACATGT-3’ and 5’-AAATTT-3’ using this method. A 
representative SPR sensorgram for the binding of diamino polyamide 5 to 5’-ACGCGT-3’ is 
depicted in Figure 3.2C. The results in Table 3.1 demonstrate that f-Im*PyIm binds more 
strongly to its cognate sequence than the two non-cognate sequences. As expected, it bound with 
the least preference for an entirely AT sequence.  
Analysis of the SPR results provided evidence that polyamide 5 interacted with 5’-
ACGCGT-3’ with a 2:1 (polyamide:DNA) stoichiometry, i.e., as a side-by-side, stacked dimer 
that fit snugly in the minor groove. K1 was calculated to be 1.8 x 105 M-1 and K2 was 3.0 x 109 
M-1, leading to a Keq of 2.3 x 107 M-1(Keq = K  K). In this case, the binding is a positively 
cooperative process. Judging from the sensorgram depicted in Figure 3.2C, it is evident that 
polyamide 5 interacted with 5’-ACGCGT-3’ with a reasonable on-rate; however, the rate by 
which the polyamide dissociated from the DNA was extremely slow. Both the thermodynamic 
and kinetic behaviors are consistent with strong  DNA binders, as was the case for polyamides 1 
and 2.5,8,14 Further analysis of the binding of 5 with 5’-ACATGT-3’, which contains two 
53 
 
mismatched base pairs in the core, gave values of K1 and K2 of 9.8 x 105 M-1 and 1.4 x 107 M-1, 
respectively. The significant reduction in cooperativity compared to the binding to 5’-ACGCGT-
3’ is consistent with earlier observations on binding of polyamides, such as distamycin, to AT-
rich sequences, such as 5’-AAATTT-3’, which show negative cooperativity.8 Presumably, the 
minor groove of AT-rich sequences is too narrow to comfortably accommodate two stacked 
polyamides.  
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Figure 3.2 (A) DNase I footprinting of f-Im*PyIm (5) with 5’-ACGCGT-3’, 5’-ACCGGT-3’, 
5’-ACACGT-3’ and 5’-AGCGCT-3’. (B) Circular dichroism data for 5 with5’-ACGCGT-3’ and 
5’-AAATTT-3’. (C) SPR sensorgrams for 5 with cognate 5’-ACGCGT-3’ and a plot of RUSS vs 
concentration including best-fit lines. (D) Raw ITC data for the “model free” titration of 5 into 
5’-ACGCGT-3’ and the integrated heats for each injection of 5 used for the titration (black dots) 
and a linear fit (black line) of that data. CD experiments were carried out using 160 µL of a 9 M 
DNA solution, which was titrated with 1 mol equivalents of 5, past the point of saturation. SPR 
experiments were performed using concentrations of 5 from 0 - 300 nM. For the ITC studies, the 
titration consisted of 30-10 µL injections of 80 µM of 3 or 5 into 30 µM DNA. The titration was 
completed up to a mole ratio of ~0.6:1 (ligand: DNA). 
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3.3.6  ITC studies  
To gain a deeper understanding on the binding of f-Im*PyIm (5) to its cognate sequence, 
ITC studies were conducted.8,20 Evidence of an exothermic interaction is apparent from the data  
in Figure 3.2D. Integration of the heat released provided the enthalpy of interaction (∆H) of -8.4 
kcal/mol. From the binding constant determined from SPR studies, the free energy of binding 
(∆G) was calculated as -10.0 kcal/mol, thereby allowing the determination of T∆S to be 1.6 
kcal/mol. For comparison, the results from the binding of f-ImPy*Im (2) to 5’-ACGCGT-3’ are 
also reported, and in this case the enthalpy was measured at -5.9 kcal/mol, which was much 
lower than that for f-Im*PyIm (5). The thermodynamic profile for 5 matched better with the 
parent molecule f-ImPyIm (1). The results are quite striking in demonstrating that small changes 
in molecular structure can significantly impact binding affinity, and at this stage it is difficult to 
predict whether the enthalpic or entropic term is more seriously affected. 
3.4  Results and discussion 
These polyamides exhibited good water solubility and they effectively inhibited the 
binding of transcription factors to dsDNA compared to other minor groove binders lacking an 
alkyl-multiamino side chain. It was suggested that upon binding, the additional cationic groups 
were attracted to the negatively charged phosphodiester groups of DNA.  
Encouraged by the spermine/spermidine results, our group reported an orthogonally 
positioned diamino polyamide f-ImPy*Im (2), in which Py* represents the N-(3-
aminopropyl)pyrrole moiety.14 The results provided validation for our hypothesis. The diamino 
polyamide (2) displayed a binding constant of 2.4 × 108 M-1 for cognate sequence 5’-ACGCGT-
3’, which was four times higher than that of its monoamino/monocationic counterpart f-ImPyIm 
(1) (5.4 × 107 M-1, when performed side-by-side). The sequence specificity of 2 was found to be 
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comparable to that of 1. Also, incorporation of the aminopropyl group in polyamide backbone of 
2 offered a significant benefit over its monocationic triamide 1 in terms of enhanced water 
solubility of its corresponding hydrochloride salt. With initial success in this strategy, we 
extended the work to explore a non-formamido polyamide, specifically diamino polyamide Ph-
ImPy*Im (3, Figure 3.1).15 Compared to its monoamino counterpart Ph-ImPyIm polyamide 4, 
diamino polyamide 3 demonstrated an excellent level of specificity for the cognate 5’-ACGCGT-
3’ sequence. In addition, the binding affinity of 3 (1.5 × 107 M-1) was enhanced by ~three-fold 
compared to its monocationic analog 4 (4.8 × 106 M-1).15 Again, the side chain of 3 was found to 
offer a significant benefit over its monocationic triamide 4 in terms of enhanced water solubility 
of the corresponding hydrochloride salt as evidenced by the ease in dissolving polyamide 3 over 
4.  
 
It is now evident that incorporation of an orthogonally positioned aminopropyl side chain 
in the polyamide backbone can afford favorable DNA binding properties. Thus far, the 
aminoalkyl moieties have been attached to the N-position of pyrrole (Py*), and that is typically 
located in the mid-section of the polyamide structure. A question arises: how will the positioning 
of an aminoalkyl group at the peripheral-section of polyamides affect the DNA binding 
properties? In the case of the f-ImPyIm frame work, what effects will f-Im*PyIm (5), in which a 
3-aminoalkyl group is attached to the N-terminus imidazole unit, have on DNA binding affinity, 
sequence selectivity, and solubility when compared to f-ImPyIm (1) and f-ImPy*Im (2). 
Accordingly, reported herein is the synthesis of f-Im*PyIm (5), which required the preparation of 
the key synthon, a derivatized imidazole-acid 6.  
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3.5  Conclusions 
Even though pyrrole and imidazole polyamides are now well known for binding strongly 
to DNA in a sequence specific manner, their potential realization as therapeutic agents is still in 
the distance. This is true particularly for the larger polyamide molecules, such as hairpins, H-
Pins, and cycles.21 Specifically, major advancements in the field that must be made are as 
follows: the molecules must demonstrate greater solubility in water, enhanced sequence 
specificity and binding affinity, and their molecular size and design must be optimized in such a 
way that it will enhance their penetration into cells and concentration in the nucleus. The 
authors’ laboratories have begun to address these challenges by focusing our efforts on 
developing small polyamides that bind in a stacked fashion, readily enter cells, concentrate in the 
nucleus, and affect gene regulation. As an example, f-PyImPy, a triamide designed to target the 
5’-flank (5’-TACGAT-3’) of the inverted CCAAT box-2 (ICB-2) was able to inhibit the binding 
of a transcriptional factor NF-Y and thereby activating the silenced topoisomerase II α gene in 
confluent cancer cells.22 Even though these results are encouraging, the binding affinity of f-
PyImPy is low (105 M-1) and that must be significantly improved, while simultaneously 
enhancing the water solubility and attraction to the DNA. The novel molecular design 
exemplified by diamino f-Im*PyIm (5), f-ImPy*Im (2), and Ph-ImPy*Im (4) offers a potential 
avenue for the creation of newer molecules that may possibly overcome some of the challenges 
in the field. 
In conclusion, the synthesis of f-Im*PyIm (5) and knowledge of its DNA binding 
properties will positively advance the polyamide field in several ways. First, it was easier to 
dissolve the diamino compound 5 in water as a hydrochloride salt than its monoamino 
counterpart 1. Second, introduction of a second positive charge in polyamides, via the 1-position 
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of the heterocycles, conferred positive effects on binding affinity and reducing dissociation rates 
of the ligand-DNA complex. Third, proper introduction of the second positive charge can 
improve sequence specificity, as is the case for f-Im*PyIm (5). Lastly, with 1-(3-chloropropyl)-
4-nitroimidazole-2-carboxylic acid 6 available in addition to its pyrrole analog, we are now 
poised to explore more broadly the novel diamino, even multiple amino, design to optimally 
target specific control regions of genes in cells. Studies to examine the cellular effects of 
polyamides 2 and 5 in controlling the expression of the Dbf4 gene are in progress. 
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Table 3.1 Results from DNase I footprinting, thermal denaturation, SPR, and ITC experiments 
on polyamides 1, 2 and 5. 
aAll experiments were performed using the appropriate sequence of DNA. bAll experiments were 
performed in PO4 buffer which contains 13 mM salt. cNot determined. 
 
 
 
 
 
 
 
 
Footprinting 
(µM)a 
∆TM (°C)b SPR (M-1) ITC (kcal/mol) 
ACGCGT AAATTT ATGCAT ACGCGT AAATTT ACATGT ACGCGT 
f-ImPyIm 
(1)5 
0.05 7.8 1 NDc 1.9 x 108 
(5.4 x 107)14 
5.3 x 104 NDc ∆H = -7.6 
∆G = -10.7 
T∆S = 3.1 
f-ImPy*Im 
(2)14 
0.05 >24 10 24 2.4 x 108 NDc NDc ∆H = -5.9 
∆G = -11.4 
T∆S = 5.5 
f-Im*PyIm 
(5) 
~0.10 >20 11 20 2.3 x 107 2.2 x 106 3.7 x 106 ∆H = -8.4 
∆G = -10.0 
T∆S = 1.6 
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CHAPTER 4: 
NOVEL DIAMINO IMIDAZOLE AND PYRROLE-CONTAINING POLYAMIDES: 
SYNTHESIS AND DNA BINDING STUDIES OF MONO- AND DIAMINO-PHENYL-
ImPy*Im POLYAMIDES DESIGNED TO TARGET 5’-ACGCGT-3’ 
 
The work presented in this chapter is based on the published paper “Novel diamino imidazole 
and pyrrole-containing polyamides: Synthesis and DNA binding studies of mono- and diamino-
phenyl-ImPy*Im polyamides designed to target 5’-ACGCGT-3’” from Bioorganic and 
Medicinal Chemistry, 2012, 20, 693-701.  Synthetic methods and write ups are attributed to Dr. 
Moses Lee of Hope College and various members of the Lee Research Group. Dr. John Hartley 
from the UK Drug-DNA Interactions Research Group is credited with the DNase I footprinting 
work and writings. My contribution to this paper was the SPR experiments, data analyses and 
writings, along with Dr. Yang Liu and Dr. W. David Wilson. 
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4.1 Abstract 
 Pyrrole- and imidazole-containing polyamides are widely investigated as DNA sequence 
selective binding agents that have potential use as gene control agents. The key challenges that 
must be overcome to realize this goal is the development of polyamides with low molar mass so 
the molecules can readily diffuse into cells and concentrate in the nucleus. In addition, the 
molecules must have appreciable water solubility, bind DNA sequence specifically, and with 
high affinity. It is on this basis that the orthogonally positioned diamino/dicationic polyamide 
Ph-ImPy*Im 5 was designed to target the sequence 5’-ACGCGT-3’. Py* denotes the pyrrole unit 
that contains a N-substituted aminopropyl pendant group. The DNA binding properties of 
diamino polyamide 5 were determined using a number of techniques including CD, ∆TM, DNase 
I footprinting, SPR and ITC studies. The effects of the second amino moiety in Py* on DNA 
binding affinity over its monoamino counterpart Ph-ImPyIm 3 were assessed by conducting 
DNA binding studies of 3 in parallel with 5. The results confirmed the minor groove binding and 
selectivity of both polyamides for the cognate sequence 5’-ACGCGT-3’. The diamino/dicationic 
polyamide 5 showed enhanced binding affinity and higher solubility in aqueous media over its 
monoamino/monocationic counterpart Ph-ImPyIm 3. The binding constant of 5, determined from 
SPR studies, was found to be 1.5 × 107 M-1, which is ~3 times higher than that for its monoamino 
analog 3 (4.8 × 106 M-1). The affinity of 5 is now approaching that of the parent compound f-
ImPyIm 1 and its diamino equivalent 4. The advantages of the design of diamino polyamide 5 
over 1 and 4 are its sequence specificity and the ease of synthesis compared to the N-terminus 
pyrrole analog 2.  
Keywords: Polyamides, diamino, dicationic, gene control, ACGCGT, MCB, Mlu1, cell-cycle 
box 
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4.2  Introduction 
Pyrrole and imidazole-containing analogs of distamycin are polyamides that bind in the 
minor-groove of DNA in a stacked fashion at specific DNA sequences.1 They are potentially 
useful for targeting and modulating the expression of genes, including those associated with 
cancer cell growth.2–4 Formamido(f)-Imidazole(Im)-Pyrrole(Py)-Imidazole(Im) (1, Figure 4.1) is 
one such polyamide (PA) molecule that selectively binds 5’-ACGCGT-3’ sequence in the minor-
groove of DNA in a 2:1 fashion (PA:DNA), with a binding affinity of 1.9 × 108 M-1.5 The 5’-
ACGCGT-3’ sequence is significant because it occurs in the core sequence of the Mlu1 cell-
cycle box (MCB) transcriptional element found in the promoter of the human DBf4 (huDbf4 or 
ASK, activator of S-phase kinase) gene. Dbf4 is the regulatory subunit of Cdc7 (cyclin 
dependent 7) kinase, and high levels of this kinase have been implicated for the development of 
various cancers.6 The formamido group at the N-terminus of such polyamides has been shown to 
influence the binding of these compounds by forcing them to stack in a ‘staggered’, rather than 
an ‘overlapped’ motif.7  
Polyamides in which the formamido group is replaced with a pyrrole or aryl groups at the 
N-terminus are known to bind in the ‘overlapped’ fashion; however, with diminished binding 
affinity but increased sequence selectivity.8 The non-formamido polyamide (2, Figure 4.1), 
which contains a pyrrole moiety at the N-terminus was synthesized while keeping the C-terminus 
dimethylamino moiety and heterocyclic core (-ImPyIm-) constant.8 It was found to retain its 
preference for binding to 5’-ACGCGT-3’, but with enhanced sequence specificity albeit with a 
25-fold lower binding affinity (7.1 × 106 M-1) compared to f-ImPyIm (1) (1.9 × 108 M-1).8 This is 
not surprising since the formamido group is known to confer enhanced binding affinity.7a,9 With 
regard to enhanced sequence selectivity, whilst f-ImPyIm (1) gave a binding affinity of 2.2 × 105 
67 
 
and 5.3 × 104 M-1 for 5’-ACCGGT-3’ and 5’-AAATTT-3’, respectively,5 PyImPyIm (2) did not 
produce binding to these two sequences at the same concentrations.8 It is apparent from these 
results that tetraamide-based structures, such as 2, are excellent templates for the design of novel 
DNA sequence specific agents for biological activity, yet having acceptable binding affinity. 
However, in our hands the synthesis of PyImPyIm (2), with a pyrrole moiety at the N-terminus, 
was cumbersome owing to susceptibility of N-methylpyrrole-2-carbonyl chloride to undergo 
polymerization during the reaction.10 Our approach to overcome this limitation is to synthesize a 
novel polyamide Ph-ImPyIm (3, Figure 4.1) by incorporating a phenyl moiety, in place of 
pyrrole, in tetraamide 2. We envisaged that incorporation of a phenyl group, instead of pyrrole, 
at the N-terminus would simplify the process due to the higher stability and ready availability of 
inexpensive benzoyl chloride. It was also anticipated that the phenyl component of such a 
polyamide would behave similarly to a non-formamido, N-terminal pyrrole unit (Py), thus 
binding to A/T base pairs. In addition, benzamides have been reported to function in a similar 
manner to pyrrole-2-carboxamides in recognizing AT-sequences of DNA.11,12 To confirm this 
hypothesis, a hitherto unreported novel polyamide, Ph-ImPyIm (3) was synthesized and 
evaluated for its DNA binding properties. 
As part of a systematic study within the authors’ laboratory our goal is to develop MCB-
targeted polyamides which can be synthesized readily yet possess excellent sequence specificity, 
stronger binding affinity, high solubility in biological media and enhanced cell penetration and 
nuclear localization properties. The strategy undertaken in our laboratory to increase the 
solubility of polyamides is inclusion of an additional amine/ammonium group in the polyamide 
structure without compromising sequence selectivity. In this strategy, the authors are aware of 
earlier reports indicating that imidazole-containing polyamides with multiple cationic groups 
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have affinity for A/T rich sequences due to attraction to the negative molecular electrostatic 
potential in the minor groove of A/T rich sequences.13,14 Hence, caution must be exercised to 
develop multiamino polyamides. In this regard, Bruice and Satz have reported that polyamides 
containing a pyrrole–N1-alkyl spermine/spermidine group target A/T rich sequences and bind 
with high affinity.15 These polyamides effectively inhibit the binding of transcription factors to 
dsDNA compared to other minor groove binders lacking an alkyl-multiamino side chain. It was 
suggested that upon binding, the additional cationic groups were attracted to the negatively 
charged phosphodiester groups of DNA. The presence of a second amino group (cationic at 
physiological pH) into the polyamide design should allow greater penetration in cells due to an 
increase in solubility of the compounds in biological media. Encouraged by these precedents, an 
orthogonally positioned diamino polyamide f-ImPy*Im (4) was synthesized in the authors’ 
laboratory.16 Investigation of DNA binding properties revealed that 4 had a binding constant that 
is 4 times higher than that of its monoamino/monocationic counterpart f-ImPyIm (1) (5.4 × 107 
M-1). The sequence specificity of 4 was found to be comparable to that of 1. Incorporation of the 
propylamino group in polyamide backbone of 4 also offered a significant benefit over its 
monocationic triamide 1 in terms of enhanced water solubility of its corresponding HCl salt. 
Hence, to exploit the benefits of having a second positively charged group in the form of an 
orthogonally positioned alkylammonium side chain, the diamino or potentially dicationic Ph-
ImPy*Im (5, Figure 4.1) was designed and synthesized, in which Py* represents the N-(2-
aminopropyl)pyrrole moiety. A comparative study of DNA recognition properties of diamino 
containing polyamide 5 with that of monoamino containing polyamide 3 is presented in Figure 
4.2. 
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4.3  Results and discussion 
4.3.1 Synthesis 
The monoamino Ph-ImPyIm 3 and the orthogonally positioned diamino/dicationic 
polyamide 5 were synthesized according to the approach depicted in Schemes 4.1 and 4.2, 
respectively. Hydrogenation of ethyl 1-methyl-4-nitroimidazol-2-carboxylate17 6 with 5% 
palladium on charcoal in ethanol followed by coupling of the resulting amine with benzoyl 
chloride in dry DCM in the presence of dry triethylamine gave ethyl 4-benzamido-1-
methylimidazol-2-carboxylate 7 in 96% yield. The ester 7 was hydrolyzed with sodium 
hydroxide in a methanol: water (1:1) mixture at reflux to obtain the corresponding carboxylic 
acid 4-benzamido-1-methylimidazole-2-carboxylic acid 8 which was coupled to amino-pyrrole-
imidazole diamide 918 using PyBOP and diisopropylethylamine in DMF at room temperature. 
The reaction afforded the monoamino Ph-ImPyIm (3) in 38% yield. Similar coupling of the acid 
8 with amino containing diamide 1016 yielded chloro compound 11, which upon treatment with 
dry ammonia in methanol at 80 °C furnished the desired diamino/dicationic polyamide 5 in 62% 
yield. 
4.3.2 DNase I footprinting studies 
The sequence specificity of the monoamino polyamide 3 and its diamino counterpart 5 
was investigated by DNase I footprinting studies19 using a 125 bp 5’-[32P]-radiolabeled 
engineered DNA fragment containing the cognate sequence 5’-ACGCGT-3’, and the non-
cognate 5’-ACCGGT-3’, 5’-ACACGT-3’ and 5’-AGCGCT-3’. The autoradiogram depicted in 
Figure 4.3A shows that the experiment with Ph-ImPyIm (3) produced a footprint at the 5’-
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ACGCGT-3’ site at 20 µM, and no other footprints were apparent even at 100 µM. The results 
for diamino polyamide 5 demonstrated superior binding affinity compared to its monoamino 
counterpart 3. The footprint for 5’-ACGCGT-3’ for diamino polyamide 5 emerged at 0.5 µM 
(Fig. 3B), which is about 10-fold lower than its formamido parent compound f-ImPyIm (1).5 
This is an exciting discovery because having the second amino group made the molecule easier 
to dissolve in aqueous solution; it has an increased binding affinity, and its binding constant for 
5’-ACGCGT-3’ compared to Ph-ImPyIm (3) is increased by a factor of about 3. In comparison 
to f-ImPyIm (1), the binding constant of diamino polyamide Ph-ImPy*Im (5) was only 10-fold 
lower. Overall, the gain in binding affinity of compound 5 over 3 was achieved without 
compromising on sequence selectivity.  
4.3.3  Thermal denaturation studies 
Thermal denaturation experiments were performed to further examine the binding of 
polyamides 3 and 5 using following DNA sequences; 5’-ACGCGT-3’, 5’-AAATTT-3’ (5’-A3T3-
3’), and 5’-ACACTT-3’. These thermal denaturation experiments provided an indication on the 
preferred binding of the monoamino polyamide 3 along with its diamino/dicationic counterpart 5 
to the DNA by measuring their ability to stabilize the DNA duplex upon heating. ∆TM values 
were determined from the differences in melting temperature of the DNA-polyamide complexes 
and duplex DNA alone and are shown in Table 4.1. In each case, 1.0 µM of DNA and 3.0 µM of 
polyamide were used. Comparable to its parent polyamide f-ImPyIm (1),5 the monoamino 
polyamide 3 showed good binding interaction with the cognate sequence 5’-ACGCGT-3’ by 
giving a ∆TM of 9 °C. It did not stabilize the other DNA sequences used in this study as 
demonstrated by the ∆TM values expressed in Table 4.1. These results indicate that the 
monoamino polyamide 3 possesses selectivity for its cognate DNA sequence 5’-ACGCGT-3’.  
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For the diamino Ph-ImPy*Im, the ∆TM value for binding to its cognate sequence 5’-ACGCGT-3’ 
is remarkable at >25 °C. It is able to stabilize the DNA significantly greater than either its 
monocationic counterpart 3 or its parent f-ImPyIm (1)5, both of which gave a ∆TM value of 9 °C. 
4.3.4 Circular dichroism studies 
CD spectroscopy was used to probe the binding of polyamides 3 and 5 in the minor 
groove of double-stranded DNA. These experiments were conducted by titrating each polyamide 
with DNA solutions comprised of the DNA sequences tested in the thermal denaturation studies. 
In all cases, a fixed DNA concentration of 9 µM was used as were the ratios of polyamides (1, 2, 
3, 4, 5, 6, and 8 molar equivalents) titrated into the solution. Both polyamides 3 and 5 bind 
effectively to their cognate sequence 5’-ACGCGT-3’as can be seen from Figure 4.4. The 
presence of a strong and positive induced CD band at ~330 nm in CD spectra shown in Fig. 4 
suggests minor grove binding for polyamides 3 and 5. The distinct isodichroic point at ~310 nm 
provides evidence that both 3 and 5 bind to the DNA sequence by a single mechanism, 
presumably by interacting in the minor groove as a stacked dimer. These results also indicate that 
an increase of one positive charge does not significantly affect sequence selectivity. The results 
also show that polyamide 5 could bind to its non-cognate sequence at the concentrations used in 
CD experiments and exhibit some tolerance for flanking base pair on either side of the central 
GC core. These results are corroborated by the aforementioned ∆TM values for 3 and 5 (Table 
4.1).  
4.3.5 Biosensor-surface plasmon resonance studies 
To obtain a more accurate measure of binding affinity and sequence selectivity plus to 
probe the stoichiometry of binding, polyamides 3 and 5 were subjected to experiments using the 
72 
 
surface plasmon resonance (SPR)-biosensor method.20 The experiments were conducted using 
cognate DNA sequence 5’-ACGCGT-3’ and non-cognate sequences 5’-AAGCTA-3’ and 5’-
AAATTT-3’. The sensorgrams recorded from the SPR experiments for 3 and 5 binding to 5’-
ACGCGT-3’ are given in Figure 4.5. According the sensorgram pattern displayed in Figure 4.5B 
, it is clearly evident that the monoamino polyamide 3 binds strongly to its cognate sequence 5’-
ACGCGT-3’ as a cooperative dimer (n~2) with a binding constant (Keq)  4.8 × 106 M-1. The 
sensorgram shown in Figure 5.5A displays a similar slow observed kinetics pattern suggesting 
that the diamino polyamide 5 also binds strongly to the cognate sequence 5’-ACGCGT-3’ as a 
cooperative dimer (n~2.2). The binding constant (Keq) of 5 to its cognate sequence was found to 
be 1.5 × 107, which is almost 3-fold higher than that of 3. This result is consistent with the results 
recorded for the DNase I footprinting experiments. Both polyamides 3 and 5 also bind to their 
non-cognate DNA sequence 5’-AAGCTA-3’, but with a lower affinity (Table 4.2). The 
monoamino Ph-ImPyIm (3) binds to 5’-AAGCTA-3’ as a dimer in a non-cooperative manner 
with binding constant (Keq) 2.5 × 105 M-1, while its diamino counterpart 5 binds to same DNA 
sequence also as a dimer but in a slightly cooperative manner with higher binding constant (Keq) 
2.1 × 106 M-1. Binding to 5’-AAGCTA-3’ is not surprising since the stacked dimer of both 
polyamides 3 and 5 contain the “ImPy” central pairing, which the authors have reported to give 
the most favorable binding to the “GC” core sequence.5 However, none of the polyamides 
showed any binding affinity to their non-cognate DNA sequence 5’-AAATTT-3’ under these 
conditions. This is not surprising since all previously reported f-ImPyIm analogs5,16 did not show 
any binding to the 5’-AAATTT-3’ (data not shown), indicating GC-sequence preference by 
Im/Py pairs. Furthermore, the enhanced binding of 5 over 3 is evidently a result of a slightly 
slower or “flatter” off-rate as revealed by the SPR sensorgrams for dicationic polyamide 5 than 
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those for the monoamino analog 3. To further elaborate on the sequence selectivity of non-
formamido polyamides, such as the phenyl-containing polyamides 3 and 5, the SPR data given in 
Table 4.2 were compared to those previously reported for f-ImPyIm (1). It is evident that whilst 
polyamides 3 and 5 did not show any binding to 5’-AAATTT-3’, f-ImPyIm (1) was reported to 
bind and it gave a binding constant of 5.3 x 104 M-1, albeit it was almost 4-orders of magnitude 
lower than the binding of compound 1 to its cognate 5’-ACGCGT-3’. This observation provided 
evidence for enhanced sequence selectivity of the phenyl-containing polyamides 3 and 5 
compared to their formamido counterpart 1. 
4.3.6 Isothermal titration calorimetry studies 
ITC experiments were performed at 25 °C to probe the thermodynamics of DNA binding 
interactions of 3 and 5. The monoamino polyamide 3 again demonstrated binding to the cognate 
sequence as evidenced by the exothermic enthalpy of binding of 3 to 5’-ACGCGT- 3’ (Figure 
4.6). Because of the very strong binding of these polyamides to the cognate DNA, a constant 
enthalpy was obtained below a mole ratio of 0.6 (Figure 4.6) where essentially all of the added 
compound is bound to DNA.  A linear fit and extrapolation back to 0.0 mole ratio gave a ∆H of 
~ -2.2 ± 0.14 kcal/mol. The similar binding interaction with 5’-ACGCGT-3’was observed for 
diamino polyamide 5 as evident from the ITC data shown in Fig. 6. A linear fit and extrapolation 
of heats back to 0.0 mole ratio yielded a ∆H of ~ -2.7 ± 0.2 kcal/mol (Fig. 6). With these ∆H 
values and the ∆G for binding from SPR (∆G = -RT ln Keq where, R is 1.987 cal mol-1 K-1 and T 
is measured in K) the T∆S values were calculated (∆G = ∆H - T∆S). The results for 5’-
ACGCGT-3’ reveal that the enhanced binding affinity, hence the free energy of binding, in the 
dicationic polyamide 5 over monocation 3 is driven more significantly by an enthalpy gain (∆∆H 
~ 0.5 kcal/mol). In contrast, the gain in entropy was smaller (∆T∆S ~ 0.2 kcal/mol). The results 
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suggest that introduction of a second amino moiety provides favorable thermodynamic 
interactions between the ammonium function and DNA, presumably via electrostatic or 
hydrogen bond interactions with the phosphate group in the DNA backbone.   
An even more drastic difference is noted by comparing the thermodynamic data of 
polyamides 3 and 5 to their parent molecule f-ImPyIm (1).5 The results given in Table 4.2 show 
that unlike the phenyl-containing polyamide whose binding was driven significantly by entropic 
means, the binding of f-ImPyIm (1) was driven primarily by enthalpy. This finding is intriguing 
and useful because it demonstrated that even a small change from N-formamido to an N-
benzamide could produce dramatic changes in the thermodynamics of interactions. The results 
indicate that in our next step of molecular design to further increase the binding affinity of 
diamino compound 5, the strategy must include elements that increase enthalpy. Such elements 
would include incorporating groups that would increase favorable intermolecular interactions.  
4.4 Conclusion 
The results from DNA binding studies show that having a second positively charged 
group in the form of an orthogonally positioned alkylammonium side chain on the polyamide 
backbone does not affect DNA sequence selectivity. In fact, the diamino polyamide  Ph-
ImPy*Im (5) demonstrated an excellent level of specificity for the cognate 5’-ACGCGT-3’ 
sequence compared to its monoamino counterpart 3. In addition, the binding affinity of 5 is 
enhanced by ~3-fold compared to its monocationic analog 3; thus, effectively raising the binding 
affinity of 5 to 5’-ACGCGT-3’ to a level that is only 10-fold lower than its parent molecule f-
ImPyIm (1). The enhanced binding affinity of 5 over 3 is possibly due to favorable electrostatic 
interaction between the negatively charged DNA phosphodiester groups and the ammonium 
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species. The side chain of 5 also offers a significant benefit over its monocationic triamide 3 in 
terms of enhanced water solubility of the corresponding HCl salts as evidenced by the ease in 
dissolving polyamide 5 over 3. Given its small size, it is our hypothesis that diamino polyamides 
such as 5 should readily be taken up by cells. Further studies to probe the ability of polyamides 3 
and 5 to affect gene function are underway and results will be reported in due course. 
4.5 Experimental 
Solvents and organic reagents were purchased from Aldrich or Fisher, and in most cases 
were used without further purification. DCM (P2O5), and DMF (BaO) were distilled prior to use. 
Melting points (mp) were performed using a Mel-temp instrument and are uncorrected. Infrared 
(IR) spectra were recorded using a Perkin Elmer Paragon 500 FT-IR instrument as films on KBr 
disks. 1H NMR spectra were obtained using a Varian Unity Inova 400 MHz instrument unless 
otherwise stated. Chemical shifts (δ) are reported at 20 °C in parts per million (ppm) downfield 
from internal tetramethylsilane (Me4Si). High-resolution mass spectra (HRMS) and low-
resolution mass spectra (LRMS) were provided by the Mass Spectrometry Laboratory, 
University of South Carolina, Columbia. Reaction progress was assessed by thin-layer 
chromatography (TLC) using Merck silica gel (60 F254) on aluminum plates unless otherwise 
stated. Visualization was achieved with UV light at 254 nm and/or 366 nm, I2 vapor staining and 
ninhydrin spray. 
4.6 Synthesis 
Ethyl 4-benzamido-1-methylimidazole-2-carboxylate (7). Ethyl 1-methyl-4-nitroimidazole-2-
carboxylate17 (6, 613 mg, 3.1 mmol) was hydrogenated over 5% palladium on charcoal in 
ethanol. The resulting amino compound was dried thoroughly under vacuum to remove traces of 
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ethanol. It was then dissolved in dichloromethane (20.0 mL) and the solution was cooled to 0-5 
°C. To the cold solution was added triethylamine (0.5 mL, 3.7 mmol) followed by benzoyl 
chloride (0.4 mL, 3.4 mmol). The reaction mixture was allowed to attain room temperature and 
then stirred for 12 h. Upon completion, the reaction was quenched with water (15.0 mL) and 
stirred for 15 min. The organic layer was separated and aqueous layer was washed with 
dichloromethane (2 × 10 mL). Combined organic layers were dried over sodium sulfate and 
evaporated to obtain a yellow oil. The crude product was purified by column chromatography 
using silica gel and 2% methanol in chloroform as the eluent system to obtain 7 as a yellow solid 
(808 mg, 96%), mp 120-125 °C, Rf: 0.76 (9.5:0.5 v/v, CHCl3:CH3OH); IR: υ 2976, 1712, 1663, 
1554, 1444, 1123, 1019, 708 cm-1; 1H NMR (CDCl3) δ 8.84 (s, 1H), 7.88-7.86  (d, 2H, J=8.0 
Hz), 7.69 (s, 1H), 7.56-7.47 (m, 3H), 4.40 (q, 2H, J=8.0 Hz), 4.05 (s, 3H), 1.42 (t, 3H, J=8.0 Hz); 
LRMS (ES+) m/z = 274 ([M+H]+, 100%). 
4-Benzamido-1-methylimidazole-2-carboxylic acid (8). To the slurry of ethyl 4-benzamido-1-
methylimidazole-2-carboxylate  (7, 800 mg, 2.9 mmol) in methanol:water (1:1, 20.0 mL) was 
added aqueous sodium hydroxide solution (2.0 M, 1.8 mL). The reaction mixture was refluxed 
for 45 min and then distilled to remove methanol. It was then made acidic (pH = 3-4) by adding 
dilute hydrochloric acid (6.0 M) to obtain 4-benzamido-1-methylimidazole-2-carboxylic acid (8) 
as a white solid which was filtered, washed with water and dried in vacuum at room temperature 
(664 mg, 85%), mp 156-158 °C, Rf: 0.24 (3:7 v/v, CHCl3:CH3OH); IR: υ 3445, 2254, 2127, 
1661, 1033, 818, 753 cm-1; 1H NMR (CDCl3) δ 11.05 (s, br, 1H), 8.04-8.06  (d, 2H, J=8.0 Hz), 
7.70 (s, 1H), 7.54-7.46 (m, 3H), 3.95 (s, 3H); LRMS (ES+) m/z = 246 ([M+H]+, 100%). 
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Monoamino Ph-ImPyIm polyamide (3). 4-Benzamido-1-methylimidazole-2-carboxylic acid (8, 
107 mg, 0.44 mmol) was dissolved in DMF (2.0 mL). To the clear solution was added PyBOP 
(230 mg, 0.46 mmol) followed by diisopropylethylamine (DIPEA, 0.15 mL, 0.87 mmol). The 
reaction mixture was stirred at room temperature for 30 min and to it was added solution of 918 
(133 mg, 0.4 mmol) in DMF (1.0 mL). The reaction mixture was stirred for 3 days at room 
temperature under argon atmosphere and then poured on water (10.0 mL). It was extracted with 
chloroform (3 × 10.0 mL) and combined organic layers were dried over sodium sulphate and 
evaporated on rotary evaporator. The crude product was purified by column chromatography 
using silica gel and 10% methanol in chloroform to obtain monoamino Ph-ImPyIm polyamide 
(3) as a yellow solid (87 mg, 38%), mp 163-165 °C, Rf: 0.53 (1:1 v/v, CHCl3:CH3OH); IR: υ 
2928, 1663, 1531, 1468, 1438, 1258, 1117, 907 cm-1; 1H NMR (CDCl3) δ 8.83 (s, br, 1H), 8.48 
(s, br, 1H), 8.09 (s, br, 1H), 7.94-7.92  (d, 2H, J=8.0 Hz), 7.62 (s, 1H), 7.55 (s, 1H), 7.53-7.51 
(m, 3H), 7.42 (s, 1H), 7.29 (s, 1H), 6.76 (s, 1H), 4.49 (q, 2H, J=8.0 Hz), 4.12 (s, 3H), 4.03 (s, 
3H), 3.98 (s, 3H), 2.55 (t, 2H, J=8.0 Hz), 2.32 (s, 6H); LRMS (ES+) m/z = 561 ([M+H]+, 100%); 
HRMS [M+H]+ calculated for m/z C27H32N10O4 561.2691; found m/z 561.2686.  
Ph-ImPy(C3H6Cl)Im (11). 4-Benzamido-1-methylimidazole-2-carboxylic acid (8, 126 mg, 0.5 
mmol) was dissolved in DMF (2.0 mL). To the clear solution was added PyBOP (280 mg, 0.55 
mmol) followed by diisopropylethylamine (DIPEA, 0.18 mL, 1.0 mmol). The reaction mixture 
was stirred at room temperature for 30 min and to it was added solution of 1016 (208 mg, 0.5 
mmol) in DMF (1.0 mL). The reaction mixture was stirred for 3 days at room temperature under 
argon atmosphere and then poured on water (10.0 mL). It was extracted with chloroform (3 × 
10.0 mL) and combined organic layers were dried over sodium sulphate and evaporated on 
rotary evaporator. The crude product was purified by column chromatography using silica gel 
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and 15% methanol in chloroform to obtain Ph-ImPy(C3H6Cl)Im (11) as a white solid (104 mg, 
34%), mp 238-240 °C, Rf: 0.44 (1:1 v/v, CHCl3:CH3OH); IR: υ 3300, 1654, 1450, 1111, 1030, 
930 cm-1; 1H NMR (CDCl3) δ 8.87 (s, br, 1H), 8.49 (s, br, 1H), 8.25 (s, br, 1H), 8.05 (s, br, 1H), 
7.94-7.92  (d, 2H, J=8.0 Hz), 7.62 (s, 1H), 7.59-7.55 (m, 3H), 7.52 (s, 1H), 7.45 (s, 1H), 7.40 (s, 
1H), 4.53 (t, 2H, J=8.0 Hz), 4.13 (s, 3H), 4.03 (s, 3H), 3.54-3.48 (m, 4H), 2.57 (t, 2H, J=8.0 Hz), 
2.33 (s, 6H), 2.31 (t, 2H, J=8.0 Hz); LRMS (ES+) m/z = 623 ([M+H]+, 50%).  
Diamino Ph-ImPy*Im polyamide (5). The solution of Ph-ImPy(C3H6Cl)Im (11, 10 mg, 0.016 
mmol) in dry methanol (5.0 mL) was purged with dry ammonia for 6.0 h in a re-sealable tube. 
The tube was sealed tightly and heated at 80 °C for 12 h. After completion of reaction, the 
solution was evaporated on a rotary evaporator to dryness to obtain the crude product. 
Purification by column chromatography (silica, gradient, 0:100-100:0%v/v, CHCl3/MeOH) gave 
the desired diamino polyamide 5 as a white solid (6.0 mg, 62%), mp 150-152 °C, Rf: 0.41 
(15:5:1% v/v, CHCl3:CH3OH:NH3); IR: υ 3421, 3359, 3310, 3080, 3000, 2973, 1651, 1541, 
1471, 1405, 1257, 1188, 1084, 1012, 847 cm-1; 1H NMR (CD3OD) δ 7.98 (d, 1H), 7.57-7.64  (m, 
6H), 7.49 (s, 1H), 7.07 (s, 1H), 4.52 (t, J=4.0 Hz, 2H), 4.13 (s, 3H), 4.05 (s, 3H), 3.52 (t, J =4.0 
Hz, 2H), 2.81 (t, J=4.0 Hz, 2H), 2.60 (t, J =8.0 Hz, 2H), 2.35 (s, 6H), 2.01 (t, J =8.0 Hz, 2H), 
2.11 (quint, J =4.0 Hz, 2H); LRMS (ES+) m/z (rel intensity) 601 ([M+H]+, 90%), 301 (100%); 
HRMS [M+H]+ calculated for C29H37N11O4 m/z 601.2635; found m/z 601.2634.  
Buffers. 10 mM phosphate buffers were prepared at the following salt (NaCl) concentrations: 
12.5 mM (PO40), 50 mM (PO45), 200 mM (PO420) with the addition of 1 mM EDTA, pH 6.2.  
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DNase I footprinting. A radiolabeled DNA fragment of 125 base pairs was generated by 
polymerase chain reaction as described previously 21 . The resulting labeled fragment was 
purified on a Bio-Gel P-6 column (Bio-Rad) followed by agarose gel electrophoresis and isolated 
using a Mermaid kit (MP biomedicals) according to the manufacturer’s instructions. DNase I 
digestions were conducted in a total volume of 8 µL. In each case, the labeled DNA fragment (2 
µL, 200 counts s
−1) was incubated for 30 min at room temperature in 4 µL of TN binding buffer 
(10 mM Tris Base, 10 mM NaCl, pH 7) containing the required drug concentration. Cleavage by 
DNase I was initiated by addition of 2 µL of DNase I solution (20 mM NaCl, 2 mM MgCl
2
, 2 
mM MnCl
2
, DNase I 0.02U, pH 8.0) and stopped after 3 min by snap freezing the samples on dry 
ice. 
The nuclease-digested samples were subsequently lyophilized to dryness and resuspended in 5 
µL of formamide loading dye (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 
0.05% xylene cyanol). Following heat denaturation for 5 min at 90 °C, the samples were loaded 
on a denaturing polyacrylamide (10%) gel (Sequagel, National Diagnostics, UK) containing urea 
(7.5 mM). Electrophoresis was carried out for 2 h at 1650 V ( 70 W, 50 °C) in 1× TBE buffer. 
The gel was then transferred onto Whatman 3MM and dried under a vacuum at 80 °C for 2 h. 
The gel was exposed overnight to Fuji medical X-Ray film and developed on a Konica Medical 
Film Processor SRX-101A. 
 
 
 
80 
 
Thermal denaturation (TM). Thermal denaturation data were obtained using the Cary 100 
BioMelt (Varian) spectrophotometer with DNA (1 µM) in PO40 and the required compound (3 
µM), using the procedure previously reported.7a Thermal melts were obtained for each 
compound using 5’-ACGCGT-3’, 5’-AAATTT-3’ and 5’-ACACTT-3’. 
Circular dichroism (CD). CD studies were performed using the Olis DSM20 instrument. Each 
run was performed over 400–220 nm wavelength range (180 increments) and an integration time 
of 1 s and the average of two scans were used for analysis. The required compound (500 µM in 
double distilled H2O) was titrated in 1 molar equivalents into the required DNA (160 µL of 9 µM 
DNA), in PO45, until saturation was observed. Data analysis was performed as previously 
described.7a CD experiments were performed with 5’-ACGCGT-3’, 5’-AAATTT-3’ and 5’-
ACACTT-3’. 
Surface plasmon resonance (SPR). SPR measurements were performed with a four-channel 
BIAcore T100 optical biosensor system (Biacore, GE Healthcare Inc.). 50-Biotin-labeled DNA 
hairpin duplex samples were immobilized onto streptavidin-coated sensor chips (BIAcore SA) as 
previously described.20 Three flow cells were used to immobilize the DNA oligomer samples, 
while a fourth cell was left blank as a control. The SPR binding experiments were performed in 
0.01M cacodylic acid (CCA) solution at pH 6.25 containing 0.001 M EDTA (disodium 
ethylenediamine tetraacetate), 0.1 M NaCl, and 0.005% v/v surfactant P20 (Biacore AB) was 
used to reduce the nonspecific binding of polyamides to the fluidics and sensor chip surface. A 
0.01 M N-[2-hydroxyethyl]piperazine-N0-[2-ethanesulfonic acid] (HEPES) solution at pH 7.4 
containing 0.15 M NaCl, 0.003 M EDTA, and 0.005% v/v surfactant P20 was used during the 
DNA immobilization process. All buffers were degassed and filtered prior to experiments. DNA 
sequences were obtained from Integrated DNA Technologies (San Diego, CA) with HPLC 
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purification and were used without further purification. The lyophilized 5’-biotin-labeled DNA 
hairpin constructs were dissolved in the appropriate amount of DI H2O to create 1.0 mM DNA 
stock solutions. Further dilutions were made using 0.01 M HEPES buffer during the DNA 
immobilization step. DNA concentrations were determined spectrophotometrically using molar 
absorptivity coefficients calculated for each individual DNA sequence by using the nearest 
neighboring method for the singled-stranded DNA method. Stock solutions of 3 and 5 were 
prepared by dissolving the solid compound in the necessary amount of distilled H2O to create a 
stock solution with a concentration of approximately 1.0 × 10-3 M. Stock solutions were kept 
frozen at 4 °C until experimental use to minimize any degradation of the compound. Samples for 
SPR experiments were prepared by a series of dilutions from the stock solution using a 0.01 M 
cacodylic acid buffer solution. The SPR experiments were conducted using a four-flow cell 
BIAcore 2000 biosensor instrument (GE Life Sciences). DNA hairpin constructs labeled with 
biotin at the 5’ end were immobilized onto a streptavidin-coated sensor chip (sensor chip SA) as 
previously reported.20a,b,22 The 5’-biotin-labeled DNA hairpins were immobilized on three of the 
four flow cells. The fourth was left blank and used as a control. All SPR experiments were 
performed at 25 °C and used 0.01 M CCA as the running buffer. The amount of DNA 
immobilized was approximately 400 response units (RU). This was achieved by continuously 
injecting ~20 µL of an approximately 50 nM DNA solution at a rate of 2 µL/min onto the sensor 
chip surface until a relative response of 400 units was reached. Binding data were obtained by 
injecting known concentrations and were analyzed with one or two site binding models as 
previously described using the following equation: 20a,b,22 
r = (K1 × ( Cfree + 2 × K1 × K2 × C2free)) /(1 + K1 × Cfree + K1  × K2  × C2free)  eq. 1 
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where, r represents the moles of bound compound per mole of DNA hairpin duplex, K1 and K2 
are macroscopic binding constants, and Cfree is the free compound concentration in equilibrium 
with the complex. 
Isothermal titration calorimetry (ITC). ITC analysis was performed using a VP-ITC 
microcalorimeter (MicroCal). Compound 3 was dissolved in 0.01 M cacodylic acid (CCA) buffer 
and the instrument equilibrated to 25 °C. ITC experiments were conducted using the “model-
free” method as previously reported.23   After an initial delay of 300 s, compound 3 (80 µM) was 
titrated, via 30 injections (10 µL for 20 s, repeated every 300 s), into 30 µM DNA (0.01 M 
CCA). The data were imported to Origin 7.0, which was used to integrate the area under the 
curve as a function of time. In order to normalize for nonspecific heat components, including 
heats of dilution, nonspecific heat component integrations were subtracted from the reaction 
integrations 5. A linear fit of the normalized ∆H (y-axis) values versus mol ratio (x-axis) was 
done using KaleidaGraph 4.0. Extrapolation back to 0 mol ratio of this plot yields the enthalpy 
(∆H) of the reaction.  The DNA used in this experiment was 5’-ACGCGT-3’, 5’-AAATTT-3’, 
and 5’-ACCGGT-3’.   
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Figure 4.2 Schematic of PyImPyIm (4) (A) and phenyl containing polyamides Ph-ImPyIm (3) 
and Ph-ImPy*Im (5) (B) binding to the cognate DNA sequence 5’-ACGCGT-3’. 
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Figure 4.3 DNase I footprinting of monoamino polyamide Ph-ImPyIm (3) (A) and diamino 
polyamide Ph-ImPy*Im (5) (B). 
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Figure 4.4 CD data for Ph-ImPyIm (3) (A) and its diamino counterpart 5 (B) with 5’-ACGCGT-
3’, 5’-AAATTT-3’ and 5’-ACACTT-3’. Data were obtained using PO45  buffer. 
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Figure 4.5 SPR sensorgrams (A) and (B) showing binding of 3 and 5 to 5’-ACGCGT-3’, 
respectively, at concentration range from 0 to 0.8 µM.  (C) Plot of r vs concentration including 
best fit lines. 
 
90 
 
 
 
Figure 4.6  (A) Raw ITC data for the “model free” titration of 3 into 5’-ACGCGT-3’.a (B) The 
integrated heats for each injection of 3 used for the titration (red dots) and a linear fit (red line) of 
that data.b  (C) Raw ITC data for the “model free” titration of 5 into 5’-ACGCGT-3’.a (D) The 
integrated heats for each injection of 5 used for the titration (red dots) and a linear fit (red line) of 
that data.b  The titration consisted of 30-10 µL injections of 80 µM of 3 or 5 into 30 µM DNA. 
The titration was completed up to a mole ratio of ~0.6:1 (ligand :DNA). b The linear fits were 
completed using KaleidaGraph 4.0. 
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Scheme 4.1 Reagents and conditions (i) H2, 5% Pd/C, ethanol, rt, 12 h; (ii) benzoyl chloride, 
TEA, DCM, rt, 12 h; (iii) NaOH, CH3OH:H2O (1:1), reflux, 45 min; (iv) PyBOP, DMF, DIPEA, 
rt, 3 days. 
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Scheme 4.2 Reagents and conditions (i) PyBOP, DMF, DIPEA, rt, 3 days; (ii) dry NH3, 
methanol, 80 °C, 12 h. 
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Table 4.1 Thermal denaturation data and DNase I footprinting data for polyamides 3, 5 and 1 
 
Polyamide 
 
5’-ACGCGT-3’ 
   ∆Tm (°C) 
5’-A3T3-3’ 
 
 
5’-ACACTT-3’ 
 
Footprinting 
(µM)a 
     
3 9 0 0 20 
5 >25 7.6 0 0.5 
1a 9 1 NDb 0.05 
aData taken from reference 5. bNot determined.  
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 Table 4.2 Binding constants of polyamides 3, 5 and 1 to DNA sequences 5’-ACGCGT-3’ 
and5’-AAATTT-3’. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polyamide 
Sequences 
5’-ACGCGT-3’ 
  
5’-A3T3-3’ 
 
   
 
 
 
3 
K1 = 6.1 × 104 M-1 
K2 = 3.7 × 108 M-1 
Keq = 4.8 × 106 M-1 
 
∆G = -9.1 kcal/mol 
∆H = -2.2 kcal/mol 
T∆S = 6.9 kcal/mol 
K1 = 2.9 × 105 M-1 
K2 = 1.2 × 107 M-1 
Keq = 2.1 × 106 M-1 
 
∆G = -8.6 kcal/mol 
∆H = -2.2 kcal/mol 
T∆S = 6.9 kcal/mol 
 
 
 
5 
K1 = 8.7 × 105 M-1 
K2 = 2.7 × 108 M-1 
Keq = 1.5 × 107 M-1 
 
∆G = -9.8 kcal/mol 
∆H = -2.7 kcal/mol 
T∆S = 7.1 kcal/mol 
NDd 
 
 
 
1a 
K1 = 1.9 × 108 M-1 
 
∆G = -9.5 kcal/mol 
∆H = -7.7 kcal/mol 
T∆S = 1.8 kcal/mol 
K1 = 2.9 × 105 M-1 
K2 = 1.2 × 107 M-1 
Keq = 2.1 × 106 M-1 
 
∆G = -8.6 kcal/mol 
∆H = -2.2 kcal/mol 
T∆S = 6.9 kcal/mol 
aBinding constants were measured by SPR. bNo response detected.  
cData taken from reference 5. dNot determined.  
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CHAPTER FIVE: 
AFFINITY AND KINETIC MODULATION OF NOVEL SYNTHETIC POLYAMIDE 
DERIVATIVES 
 
The work presented in this chapter is based on a paper “Affinity and kinetic modulation of novel 
synthetic polyamide derivatives” which has currently been submitted to Biochemistry for 
publication.  I am the 1st author of this manuscript and also conducted all of the SPR and ITC 
experiments, data analyses and writings, along with Dr. Yang Liu and Dr. W. David Wilson.  
Synthetic methods and write ups are attributed to Dr. Moses Lee of Hope College and various 
members of the Lee Research Group. Dr. John Hartley from the UK Drug-DNA Interactions 
Research Group is credited with the DNase I footprinting work and writings.  
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5.1 Abstract 
Synthetic N-methyl imidazole and N-pyrrole containing polyamides that can form 
“stacked” dimers can be programmed to target and bind to specific DNA sequences and control 
gene expression.  In order to accomplish this goal, the development of polyamides with lower 
molecular mass which allows for the molecules to rapidly penetrate cells and localize in the 
nucleus, along with increased water solubility, while maintaining DNA binding sequence 
specificity and high binding affinity, is key.  In order to meet these challenges, six novel f-
ImPy*Im  polyamide derivatives that contain different orthogonally positioned  moieties were 
designed to target 5’-ACGCGT-3’. The synthesis and biophysical characterization of six f-
ImPy*Im were determined by CD, ∆TM, DNase I footprinting, SPR, and ITC studies, and were 
compared with those of its parent compound, f-ImPyIm.  The results gave evidence for the minor 
groove binding and selectivity of polyamides 1 and 6 for the cognate sequence 5’-ACGCGT-3’, 
and with strong affinity Keq = 2.8 x 108 M-1 and Keq = 6.2 x 107 M-1, respectively.  The six novel 
polyamides presented in this study demonstrated  increased water solubility, while maintaining 
low molecular mass, sequence specificity, and binding affinity, addressing key issues in 
therapeutic development. 
 
Keywords: Polyamides, diamino, dicationic, gene control, ACGCGT, MCB, Mlu1, cell-cycle 
box, pyrrole, imidazole, DNA, minor groove binder, sequence selectivity, binding affinity, 
kinetics 
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5.2 Introduction 
Synthetic pyrrole (Py) and imidazole (Im) containing analogs (Figure 5.1) of the naturally 
occurring polyamide compounds distamycin and netropsin have been shown to selectively bind 
as a “stacked” dimer to the minor groove of DNA with high affinity and selectivity (1-3).  The 
addition of a formamido (f) group to the N-terminus of polyamides (PA) increases the binding 
affinity and causes the stacking to be in a “staggered” position as opposed to “overlapped” 
stacking (4-8). Because of their high affinity and sequence selectivity, polyamides have 
demonstrated potential as therapeutics. Based on their ability to target, alter and control gene 
expression, especially those genes associated with such diseases as cancer, polyamides are of 
interest for the design and development of new types of therapeutics (9-16). 
The polyamide, f-ImPyIm (Figure 5.1), binds to the sequence 5’-ACGCGT-3’ as a 
stacked, staggered homodimer with a (quite) high binding affinity, Keq > 108 M-1, for a small 
molecule (5, 6, 8, 17, 18).  The sequence 5’-ACGCGT-3’ is of significance due to its occurrence 
in the core sequence of the Mlu1 cell-cycle box (MCB), a transcriptional element found in the 
promoter region of the human Dbf4 (huDbf4 or ASK, activator S-kinase) gene.  High levels of 
Cdc7 (cyclin dependent) kinase have been implicated in the development of various cancers and 
Dbf4 is a regulatory subunit of this kinase (19-23). 
Our approach to developing modified derivatives of polyamides, such as f-ImPyIm, as 
therapeutic candidates is to develop analogues that will facilitate an increase in binding affinity, 
sequence selectivity, solubility, and biological activity, including cellular uptake and nuclear 
localization.  An attractive approach for the design of potentially improved analogues of f-
ImPyIm is the addition of different functional groups at the N5-position of the center pyrrole 
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coupled with a detailed study of their DNA binding affinity and sequence selectivity.  To initiate 
this investigation six different f-ImPy*Im analogs were synthesized (shown in Figure 5.1), where 
Py* is the modified heterocycle, and their binding properties were examined using surface 
plasmon resonance (SPR), isothermal titration calorimetry (ITC), DNase I footprinting, thermal 
denaturation, and circular dichroism (CD).  All synthesized polyamides investigated in this study 
retain the same f-ImPy*Im core and, therefore, have the same 5’-ACGCGT-3’ cognate sequence. 
5.3 Experimental 
5.3.1 Surface Plasmon Resonance 
SPR measurements were performed with a four-channel Biacore T200 optical biosensor 
system (Biacore, GE Healthcare Inc.). 5’-Biotin-labeled DNA hairpin duplex samples were 
immobilized onto a streptavidin-coated sensor chip (Biacore SA) as previously described (5-8, 
17, 18). All SPR experiments were performed at 25 °C and used 0.01 M cacodylic acid (CCA), 
0.1 M NaCl, 0.001 M ethylenediaminetetraacetic (EDTA), 0.05% (by vol) P20 surfactant, and 
pH 6.25 as the running buffer. The amount of DNA immobilized was approximately 400 
response units (RU). This was achieved by continuously injecting ~20 µL of an approximately 
50 nM DNA solution at a rate of 2 µL/min onto the sensor chip surface until a relative response 
of 400 units was reached. Binding data were obtained by injecting known concentrations over 
each flow cell of the chip and were analyzed with a two site binding model as previously 
described (24-26): r = (K1 × (Cfree + 2 × K1 × K2 × C2free)) / (1 + K1 × Cfree + K1  × K2  × C2free) 
where r represents the moles of bound compound per mole of DNA hairpin duplex, K1 and K2 
are macroscopic binding constants, and Cfree is the free compound concentration in equilibrium 
with the complex.  The stoichiometry of the reaction, n, can be determined directly from an SPR 
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experiment.  This is best determined by an experiment in which the concentration of injected 
molecules (flow solution of ligand) flowed over each cell of the chip and this leads to no change 
in RUobs when an increase in concentration occurs (24, 26).  This is the steady-state RU value.  
For the binding of a small molecule, such as the polyamides presented in this study (PA), to a 
specific DNA site (NA) immobilized on the chip, to form a polyamide/DNA complex, the 
RUmax/pred is dependent on the amount of immobilized DNA, RUNA, the molecular weights of 
both the polyamide (MPA) and the immobilized DNA component (MNA), and the refractive index 
(n  , with the concentration (c)  for polyamide (dn /dc)PA and DNA (dn /dc)NA given the 
equation: 
RUmax/pred = RUNA × (MPA/MNA) × [(dn/dc)PA/(dn/dc)NA]  Eq. 1 
RUobs, the steady-state response, for a reaction depends on the fraction of DNA sites with 
compound bound, fbound, for each concentration of ligand flow solution and the stoichiometry, n, 
given the equation: 
RUobs = RUmax/pred × n × fbound      Eq. 2 
At the maximum, where fbound  is equal to 1, the stoichiometry, n, is given by: 
n = (RUmax)obs / (RUmax)pred      Eq. 3 
K1 and K2, which are dependent on fbound, are determined by plotting steady-state RUobs 
values from eq. 2 versus concentration of free ligand (Cfree) (24, 26), as shown in Figure 5.2B.  
The plot of RUobs(ss) versus Cfree is fit using KaleidaGraph 4.0 software and a defined model for 
2:1 binding based on the stoichiometry and is given on page 99.  The binding process is 
considered to be cooperative when K2 is at least four times greater than K1. 
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5.3.2 Isothermal Titration Calorimetry (ITC) 
ITC analysis was performed using a VP-ITC microcalorimeter (MicroCal, MA). The 
DNA and compound sample were prepared in the exact same [0.01 M cacodylic acid (CCA), 0.1 
M NaCl, 0.001 M ethylenediaminetetraacetic acid (EDTA), pH 6.25] buffer solution.  The 
instrument was equilibrated at a temperature of 25 °C (298 K). The ITC experiments were 
conducted using the “excess DNA” method (“model-free” method), where an excess of DNA is 
used and does not allow for the reaction to reach an equilibrium end point, as previously reported 
(27-29).  Briefly, after an initial delay of 300 s, compounds (80 µM) were titrated via 30 
injections (10 µL for 20 s, repeated every 300 s), into 30 µM DNA.  All ITC experiments were 
repeated in triplicate and reproducibility noted. The data were analyzed using the same method 
as previously reported (29). Origin 7.0 was used and the area under each curve integrated as a 
function of time. A linear fit of the integrated heats was then employed using KaleidaGraph 4.0 
and this was subtracted from the reaction integrations to normalize for nonspecific heat 
components. ∆G was calculated from ∆G = -RT ln Keq, where, R is 1.987 cal mol-1 K-1 and T is 
measured in K. 
5.3.3 DNase I Footprinting  
DNase I footprinting experiments were conducted using a 130-bp 5’-[32P]-radiolabeled 
DNA fragment to determine sequence specificity for polyamides 1-6.  The engineered DNA 
fragment contained each of the following sequences, the cognate sequence 5’-ACGCGT-3’, as 
well as two other DNA sequences with the same CG composition in differing arrangements, 5’-
AGCGCT-3’ and 5’ACCGGT-3’. The protocol was reported previously (6). 
102 
 
5.3.4 Thermal Denaturation 
Thermal denaturation studies were performed in duplicate using a Cary Bio 100 
spectrophotometer UV/vis instrument (Palo Alto, CA) and cells with a 10 mm pathlength using a 
previously reported method (6).  This method was used to support the sequence selectivity of 
polyamides 1-6 demonstrated by DNase I footprinting analyses (6).  ∆TM values were determined 
from the difference in melting temperatures of the DNA-polyamide complex and duplex DNA 
alone. For each experiment 1.0 µM of DNA and 3.0 µM of polyamide were used. 
5.3.5 Circular Dichroism (CD) 
CD spectroscopy was used to probe the binding of polyamides 1-6 in the minor groove of 
double-stranded DNA using an OLIS (Bogart, GA) DSM20 spectropolarimeter with a 10 mm 
path length cuvette and a band pass of 2.4 nm (6). These experiments were conducted in 
duplicate by titrating each polyamide with DNA solutions comprised of the DNA sequences 
tested in the thermal denaturation studies. In all cases, a fixed DNA concentration of 9 µM was 
used as were the ratios of polyamides (1, 2, 3, 4, 5, 6, 8, and 10 molar equivalents) titrated into 
the solution.  
5.3.6 Synthesis 
f-IP(C3NH2)I (1) 
The synthesis of diamino f-IPI (1) was reported earlier (22). A more efficient synthetic 
approach is reported herein. A solution of f-IP(C3Cl)I (2) tail (100 mg, 0.183 mmol) in dry 
MeOH (5 mL) in a sealed tube was purged with dry NH3 (g) for 6 h. The tube was sealed tightly 
and heated at 60 ºC for 24 h. The solvent was removed by evaporation and the residue purified 
by flash column chromatography eluting in MeOH:CHCl3 (0:100-100:0) to give diamino f-IPI 
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(1) as a  yellow solid (30 mg, 31%). The 1H-NMR spectrum is identical to the product obtained 
from hydrogenation of the azide precursor (22). 
f-IP (C3Cl)I  (2) 
Nitro-IP(C3Cl)I (200 mg, 0.366 mmol) was reduced in the presence of hydrogen over 5% 
Pd/C (100 mg) in cold MeOH (100 mL) for 18 h. The reaction mixture was filtered over celite 
and the catalyst washed thoroughly with MeOH. The solvent was removed by evaporation and 
the residual MeOH removed by co-evaporation with dry DCM (3× 2 mL). The resulting product, 
a dark orange solid, was dried under high vacuum while being protected from light. Formic acid 
(1 ml, kept at 0 ºC prior to use) was added to acetic anhydride (2 ml) at 0 ºC and the solution 
heated at 50 ºC for 30 min. The solution was then added to an ice-cold solution of amine in dry 
DCM dropwise (~ 10 min.) and the solution stirred overnight. The excess anhydride was 
quenched with methanol (30 ml), and the solvent removed by evaporation. A basic aqueous 
work-up was performed and the residue purified by flash column chromatography eluting in 
MeOH:CHCl3 (0:100-100:0) to give chloro f-IPI (2) as a yellow solid (113 mg, 56.3%); Rf: 
[MeOH:CHCl3 (50:50)] 0.43; mp. 122 ºC; IR: υ (NaCl) cm-1 3390, 3184, 2925, 2359, 1651, 
1537, 1384, 1070;  1H-NMR δH (400 MHz, CDCl3 ) 8.11 (1H, s), 7.86 (2H, d, J 2), 7.40 (1H, s), 
7.37 (2H, d, J 2), 4.54 (2H, t, J 6), 4.23 (3H, s), 3.57 (2H, q, J 7), 3.5 (2H, t, J 6.2), 2.56 (2H, s), 
2.34 (2H, t, J  6), 2.18 (3H, s); LRMS (ES+) m/z (rel intensity) 548 ([M+H]+, 100%); HRMS 
[M+H+, C23H31ClN10O4+] calculated: 547. 2294. Found: 547.2286.  
f-IP(C3N3)I (3) 
To a solution of the chloro-polyamide fIP(C3Cl)I (185 mg, 0.342 mmol) was added NaN3 
(103 mg, 1.58 mmol) in dry DMF (2 mL). The solution was heated at 80 °C overnight. The DMF 
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was removed by Kugelrohr distillation, a basic aqueous work-up performed and the residue 
purified by flash column chromatography eluting in MeOH:CHCl3 (0:100-100:0) to give azido f-
IPI (3) as a yellow solid (180 mg, 0.33 mmol, 95.8%); Rf: [MeOH:CHCl3 (30:70)] 0.33; mp 112 
ºC; IR: υ (NaCl) cm-1  3329, 2921, 2359, 2099, 1659, 1531, 1470, 1402, 1082; NMR δH (400 
MHz, CDCl3) 8.85 (1H, s,), 8.37 (1H, s), 7.45 (1H, s), 7.39 (1H, s), 7.31 (1H, s), 6.85 (1H, s), 
4.45 (2H, t, J 4.2 Hz), 4.08 (3H, s), 4.03 (3H, s), 3.49 (2H, t, J 4.2 Hz), 3.32 (2H, quart, J 4.2 Hz) 
2.54 (2H, t, J 4.2 Hz), 2.32 (6H, s), 2.10 (2H, quint, J 4.2 Hz); LRMS (ES+) m/z (rel intensity) 
554 ([M+H]+, 100%); HRMS [M+H+, C23H32N13O4+] calculated: 554.2700. Found: 554.2692. 
f-IP(C3alkyne)I (4) 
NO2P(C3alkyne)I tail (100 mg, 0.241 mmol) was reduced in the presence of SnCl2•2H2O 
(354 mg, 1.57 mmol) and 12 M HCl (1.1 mL) while refluxing in ethanol for 2 h. The reaction 
mixture was poured into water and the pH brought to 10 (2M NaOH). The solution was extracted 
with chloroform, the organic layers dried over anh. Na2SO4 and the solvent removed by 
evaporation. The corresponding amine was allowed to dry under high vacuum for 30 min. 
DiPEA (0.21 mL, 0.97 mmol) was added to a solution of 1-methyl-4-N-formamidoimidazole-2-
carboxylic acid (30) (45 mg, 0.26 mmol) and PyBOP (138 mg, 0.265 mmol) in dry DMF under 
argon atmosphere DiPEA (0.21 mL, 0.97 mmol) and allowed to stir for 45 min. The dried amine 
was added to the activated acid in dry DMF over a period of 10 min. The solution was allowed to 
stir overnight. The DMF was removed by Kugelrohr distillation and the residue purified by flash 
column chromatography eluting in MeOH:CHCl3 (0:100-100:0) to give alkynl f-IPI (4) as a light 
pink solid (38 mg, 24%); Rf: [MeOH:CHCl3:liq NH3 (5:15:1)] 0.31; mp 197-200 ºC; IR: υ (KBr) 
cm-1 3373, 3285, 2950, 2113, 1669, 1663, 1539, 1472, 1405, 1243, 1123, 1018, 904, 752; 1H-
NMR δH (400 MHz, CDCl3) 8.81 (1H, br s), 8.37 (1H, s), 8.18 (1H, br s), 7.58 (1H, s,), 7.46 (1H, 
105 
 
s), 7.37 (1H, s), 7.26 (1H, s), 4.59 (2H, t, J 6 Hz), 4.08 (3H, s), 4.02 (3H, s), 3.50 (2H, q, J 8.0 
Hz), 2.56 (2H, t, J 6.0 Hz), 2.35 (6H, s), 2.30 (2H, t, J 5.6 Hz), 2.01 (3H, m); LRMS (ES+) m/z 
(rel intensity) 571 ([M+H]+, 75%); HRMS [M+H+, C25H31ClN10O4+] calculated: 571.2300. 
Found: 571.2297. 
f-IP(C3NHCOCH3)I (5) 
Acetyl chloride (24 µL, 0.034 mmol) was added dropwise to a solution of fIP(C3NH2)I 
tail (18 mg, 0.03 mmol) and dry Et3N (4 µL, 0.03 mmol) in dry DCM (10 mL) and the solution 
stirred overnight. The solution was quenched with water and pH brought to 7 (1M NaOH). The 
solution was extracted with DCM (3 x 10 mL), the organic layers dried over anh. Na2SO4 and the 
solvent were removed by evaporation to yield a brown residue purified by flash column 
chromatography eluting in MeOH:CHCl3 (0:100-100:0) to give acetamido f-IPI (5) as a light 
yellow solid (15 mg, 79%). Rf: [MeOH:CHCl3:liq NH3 (5:15:1)] 0.27; IR: υ (ATR) cm-1 3482, 
3257, 3079, 2952, 1654, 1630, 1551, 1534, 1455, 1438, 1306, 1257, 1211, 1185, 1167, 1151, 
1126, 1090, 1053, 1039, 1013, 897, 864, 797, 775, 760, 670, 687, 656, 618, 575, 469, 447, 431, 
415, 406; NMR δH (400 MHz, CDCl3) 8.90 (1H, s), 8.41 (1H, s), 8.38 (1H, s), 8.33 (1H, s), 7.72 
(1H, s), 7.45 (2H, s), 7.36 (2H, s); 6.86 (1H, s); 4.41 (2H, t, J 4.0 Hz); 4.07 (3H, s); 4.03 (3H, s); 
3.52 (2H, q, J 4.0 Hz); 3.23 (2H, q, J 4.0 Hz); 2.60 (2H, t, J 4.0 Hz); 2.36 (6H, s), 2.01 (5H, m); 
LRMS (ES+) m/z (rel intensity) 570 ([M+H]+, 100%); HRMS [M+H+, C25H35N11O5+] calcd: 
570.2909. Found: 570.2901. 
f-IP(C3gly)I (6) 
A solution of f-IP(C3 N-Cbz glycine)I (10 mg, 0.0139) was reduced in the presence of 
hydrogen over 10% Pd/C (10 mg) in cold MeOH (10 mL) for 2 days. The solution was filtered 
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through celite and the solvent removed by evaporation to yield glycine f-IPI (6) as a white solid 
(3 mg, 37%); Rf: [MeOH:CHCl3:liq NH3 (5:15:1)] 0.27;  mp. 180 oC; IR: υ (ATR) cm-1 2961, 
1649, 1533, 1465, 1437, 1401, 1260, 1985, 1019, 894, 865, 767, 759, 693, 677, 666, 655, 623; 
NMR δH (400 MHz, CD3OD ) 8.25 (1H, s); 7.44 (2H, s); 7.02 (1H, s), 4.43 (2H, t, J 6Hz), 4.05 
(3H, s), 4.02 (3H, s), 3.55 (4H, t, J 6Hz), 3.26 (2H, t, J 8 Hz), 2.80 (2H, t, J 6 Hz), 2.51 (6H, s), 
2.03 (2H, quint, J 6 Hz); LRMS (ES+) m/z (rel intensity) 585 ([M+H]+, 25%), 293 (100%); 
HRMS [M+H+, C25H36N12O5+] calculated: 585.3008. Found: 585.3010. 
5.4 Results  
Synthesis of the target polyamides 1-6 were accomplished using solution phase aromatic 
amine – acid chloride or carboxylic acid coupling reactions. The synthesis of diamino f-ImPyIm 
(1) has recently been reported by us, and that involved catalytic hydrogenation of the 
corresponding azide f-ImPyIm polyamide (3)(22). Herein we report chloro f-ImPyIm (2) could 
be directly converted to diamino (1) through direct displacement of the chloride atom by 
ammonia via the SN2 reaction. The isolated yield of (1) was 31%. The synthesis and 
characterization of polyamides 2 and 3 are given in the experimental section. The pyrrole-N1-
alkylamino group in polyamide 1 was readily acylated by acetyl chloride to give acetamido f-
ImPyIm (5) in 79% yield. Also, reaction of the amino group with N-Cbz-glycine in the presence 
of EDCI gave the protected glycine intermediate in 42% yield. Final removal of the Cbz group 
by catalytic hydrogenation afforded the desired glycine f-IPI polyamide (6) in 37% yield. The 
preparation of alkyne f-ImPyIm (4) required a 4-nitropyrrole-N1-pentyne synthon, which was 
coupled to a C-terminus imidazole moiety.  Reduction of the nitro group using acidic stannous 
chloride and subsequent coupling of the amine with N-foramido-1-methylimidazole-2-carboxylic 
acid using PyBOP and DiPEA afforded the desired polyamide (4) in 24% yield.  
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Surface Plasmon Resonance 
Surface plasmon resonance (SPR) biosensor experiments were performed to obtain 
quantitative measurements of the binding affinities, stoichiometries, and selectivities of 
polyamides 1-6.  Sensorgrams for the binding of polyamide 6 to the cognate sequence 
(5’ACGCGT-3’) are shown as an example in Figure 5.2. The sensorgrams and fitting of the data 
show a strong, highly positive cooperative process for binding polyamide 6 to the sequence 5’-
ACGCGT-3’with a concentration dependent observed on-rate, as expected, for a polyamide-
DNA complexation process and a first-order, extremely slow off-rate.  Steady-state RU values 
were obtained by equilibrium fitting and the observed RUmax values clearly indicate a 2:1 
complex formation.  The calculated binding constants for polyamide 6 were K1 = 2.4 × 105, K2 = 
1.1 × 109, and Keq =1.6 x 107, where Keq = K  K, and were determined using a 2:1 binding 
model. The binding constants for compounds 1-6 are listed in Table 5.1 and were calculated 
using the same 2:1 binding model. Polyamide 1 exhibited the strongest overall binding to the 
cognate DNA sequence, 5’-ACGCGT-3’.  Binding affinities for polyamide 4 were not 
determined by SPR because the compound aggregated and exhibited surface problems with the 
biosensor flow cells, something occasionally observed with non-polar polyamides. The binding 
affinity and kinetic behaviors for polyamides 1-3, 5, and 6 are consistent for strong DNA 
binders.  The rate of dissociation, kd, for polyamide 6 is extremely slow as shown in Figure 5.2.  
Because of the extremely slow off-rate for polyamide 6, an accurate value for kd could not be 
determined by a kinetic fit of the data.  This is also true for polyamides which have an extremely 
fast on-rate (ka).  At higher concentrations the rate of association (ka) of polyamide 6 with its 
cognate DNA sequence (5’-ACGCGT-3’) is too fast and a kinetic fit of the data would not 
produce an accurate value for ka.  However, it is possible to estimate an apparent half-life for the 
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dissociation of the polyamide-DNA complex from the sensorgrams.  These are very useful for 
comparison and are included in Table 5.3. The apparent half-life for the dissociation of the 
dicationic polyamides, 1 and 6, from the polyamide-DNA complex are >8.3 and 4.2 hours, 
respectively.  The higher binding affinities for polyamides 1 and 6 are the direct result of the 
extremely slow rate of dissociation of the polyamides from the DNA complex.   
Isothermal Titration Calorimetry 
To better understand the interactions of polyamides 1-6 with the DNA sequence 5’-
ACGCGT-3’, ITC experiments were conducted and complete thermodynamic profiles were 
obtained (Table 5.1).  An ITC titration thermogram and the corresponding integrated heats of the 
reaction for polyamide 6 with the sequence 5’ACGCGT-3’ are shown as an example in Figure 
5.3. The excess DNA method for ITC is employed to determine ∆H and not Keq because some of 
the binding affinities are generally too high to be determined by ITC.  Since binding affinities are 
determined via SPR, there is not a need to use ITC to determine that particular thermodynamic 
parameter.  The excess DNA method for ITC allows for a very accurate determination of ∆H 
since a consistent measurement of Q (heat) over a molar range of ~0.6:1 (moles of DNA: moles 
ligand) allows for the precise linear fit and extrapolation back to zero mol ratio and the ∆H of the 
reaction (27, 29).  The enthalpy of the reaction for polyamide 6 (∆H) is -4.5 kcal/mol from the 
linear fit of the integrated heats shown in Figure 5.3.  The Gibbs-Free energy (∆G) for the 
interactions of polyamides 1-6  with the cognate DNA sequence 5’-ACGCGT-3’ are collected 
with ∆H values in Table 5.1. ∆G of the reaction for polyamide 6 with 5’-ACGCGT-3’ is 
favorable and was calculated to be -9.8 kcal/mol. T∆S for the interaction of polyamide 6 is 
calculated to be 5.3 kcal/mol using the ∆G value determined by SPR and the ∆H value 
determined by ITC.  The binding of polyamide 6 to its cognate sequence is thus driven by a 
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combination of both favorable enthalpy and entropy contributions, though a slightly larger 
entropy contribution is noted.  Polyamides 1 and 5 have very similar enthalpy and entropy 
contributions but are all enthalpically driven (Table 5.1). 
Thermal Denaturation 
Thermal denaturation studies were used as an initial evaluation of the affinity and  
sequence specificity of polyamides 1-6 using the DNA sequences 5’-ACGCGT-3’ and 5’-A3T3-
3’.  Melting temperatures (∆Tm) values were determined from the difference in melting 
temperatures of the DNA-polyamide complex and duplex DNA alone. ∆Tm for polyamides 1-6 
for both sequences are shown in Table 5.2.  Polyamides 1 and 6, with cationic substituents, 
showed very high ∆Tm values of 24 and 20 °C for the sequence 5’-ACGCGT-3’, respectively.  
∆Tm values for polyamides 2-4 and 4 with 5’ACGCGT-3’were less remarkable.  All six 
polyamides showed little or no change in Tm value with the sequence 5’A3T3-3’, as shown in 
Table 5.2. 
DNase I Footprinting 
DNase I footprinting studies provide the sequence selectivity of each polyamide 
synthesized for this study.  The autoradiogram given in Figure 5.4 shows that a footprint for 
polyamide 2 at the 5-‘ACGCGT-3’ sequence is clearly evident at a concentration of 1 µM .  No 
footprints other than for the cognate sequence appear for polyamide 2. The audiogram for 
polyamide 1 shows a footprint emerging at 0.01 µM and a clear footprint by 0.05 µM for the 
sequence 5’-ACGCGT-3’ (Table 5.2).  This supports the SPR results showing that polyamide 1, 
the diamino derivative, exhibits the highest binding affinity to the cognate sequence 5’-
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ACGCGT-3’.  Table 5.2 lists the concentrations at which a clear footprint was evident for the 
sequence 5’-ACGCGT-3’ for all six polyamides. 
Circular Dichroism 
Further investigation of the binding properties of polyamides 1-6 were evaluated using 
circular dichroism (CD) studies and the results for polyamide 6 are shown in Figure 5.5.  The 
titration of polyamide 6 into the cognate oligonucleotide 5’-ACGCGT-3’ produced a strong, 
positive DNA- induced band at ~330 nm which is indicative of the compound binding to the 
minor groove of DNA (5, 6, 8, 17, 18, 22, 23).  A weaker induced CD band was observed for the 
noncognate sequence 5’-A3T3-3’.  Compounds 1-5 also showed a DNA-induced band at 330 nM, 
thus indicating all these polyamides also bind to the minor groove of DNA.  Further evidence 
that the polyamides are binding to the DNA via a single mechanism is the presence of an 
isodichroic point for the overlaid spectra at ~310 nM (shown for polyamide 6 in Figure 5.5), 
most likely as a stacked homodimer.  This holds true for compounds 1-5 also. 
5.5 Discussion  
Since discovery and isolation of netropsin by Finlay et al. over sixty years ago (31), the 
study of netropsin, distamycin and their complexation with AT-rich sequences of the minor 
groove of DNA has become well recognized and accepted (3, 5, 32-35).  The discovery that 
distamycin could form a “stacked”, antiparallel dimer in the minor groove of DNA of varying 
AT sequences opened the door and created a rationale for synthetic polyamide drug design based 
on DNA sequence (3, 5, 32, 33, 36-42).  The systematic definition of Im and Py containing 
synthetic polyamides binding rules for sequence specific base pair recognition of the minor 
groove for Watson-Crick duplex DNA by Dervan and co-workers has paved the way for the 
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development of an unlimited library of synthetic polyamides which can be programmed to bind 
to any particular DNA sequence (5, 43-45).  Several groups have developed a wide range of 
synthetic polyamide monomers which bind to the minor groove of DNA as “stacked” dimers. 
Polyamides have shown excellent in-vitro activity, however, the development and progress of 
polyamides as therapeutics has been hindered by their inadequate solubility and cellular uptake, 
even as several positive in-vivo results have been reported (9, 46-57).   
An underutilized development area is modification of the N5-position of the pyrrole and 
imidazole ring systems.  While a number of changes have been reported at that position and H-
pin polyamides are linked through the same N5-position of the center heterocycle, more detailed 
studies with systematic modifications are needed.  To accomplish this goal we added alkyl 
cationic groups to the N5-position and have now extended the systematic analysis with the 
analogs shown in Figure 5.1. 
The strategy is to functionalize polyamides through the addition of six different alkyl side 
chains at the N5-position of the central pyrrole heterocycle and monitor their impact on sequence 
selectivity and binding affinities.  The importance of using f-ImPy*Im derivatives to target the 
sequence 5’-ACGCGT-3’ is the presence of that particular sequence in the promoter region of 
the core sequence of the Mlu1 cell-cycle box which is a transcriptional element of the human 
Dbf4 gene.  Again, the Dbf4 gene is a regulatory subunit of the Cdc7 kinase (a cyclin dependent 
kinase) which in high levels has been implicated in various cancers.  
The parent polyamide, f-ImPyIm, has a very high binding affinity and of the analogs has 
a better affinity for 5’-ACGCGT-3’ with the exception of polyamide 1 which is within 
experimental error of the parent compound (Table 5.1).  Polyamides 1 and 6 demonstrated the 
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highest binding affinity of the new f-ImPyIm analogue compounds to the cognate sequence 5’-
ACGCGT-3’with good sequence selectivity.  Both of these polyamides have a second positive 
charge that contributes to the higher binding affinities compared to the other four polyamide 
derivatives.  This is presumably due to an additional electrostatic interaction between the 
positively charged NH3+ present on the distal end of the alkyl side chain on both polyamides 1 
and 6 and the negatively charged phosphate backbone of DNA.  The length of the alkyl side 
chain allows it to extend out of the minor groove of the DNA and interact electrostatically with 
the phosphate back bone.  The larger enthalpic contribution to the overall Gibbs-free energy of 
the reaction for polyamide 1 binding to the sequence 5’-ACGCGT-3’ would support this 
explanation for the increased binding affinity.  The cationic modification of polyamide 6 is more 
bulky than the substituent of polyamide 1 and this clearly causes some steric hindrance and 
reduced binding affinity.  The uncharged compounds bind significantly more weakly than the 
parent f-ImPyIm as well as the dicationic compounds.  This again probably represents some 
decrease in DNA interactions due to steric effects without the favorable interactions of a second 
cation. 
Modulation of the rate of association and/or dissociation is another tool to modify and 
change the biological activity of polyamides.  This study demonstrates that by making systematic 
modifications to polyamides, such as f-ImPyIm, the binding affinity can be altered through the 
modulation of kd and/or ka.  More detailed work must be conducted to see if there are possible 
trends in the effects of modifying polyamides designed to target specific DNA sequences has on 
the rate of polyamide-DNA complex formation and complex dissociation.  
The dicationic polyamides 1 and 6 demonstrated comparable binding affinities to that of 
the parent compound f-ImPyIm while having increased water solubility.  Increased water 
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solubility addresses one of three major advancements that must be made in order for polyamides 
to be become potential therapeutics.  While the dicationic compounds showed an increase in 
water solubility, the other two major areas of concern, sequence specificity and binding affinity, 
remained within experimental error of the parent compound, f-ImPyIm.  The binding affinity for 
both dications remained comparatively the same to the parent compound because of the 
modulation of the rate of dissociation of the polyamide-DNA complex.  Polyamides have the 
potential to control and modulate gene expression but in order to do so, they must readily enter 
the cells and localize in the nucleus.  Along with increased water solubility, the two dicationic 
derivatives have more potential as therapeutic candidates over hairpin, H-pin and cyclic 
polyamides because of their smaller molecular weights and molecular design, thus, allowing 
them to penetrate into cells and localize in the nucleus.   
In summary, there is a need to develop a library of modified polyamides which target 
DNA and exhibit improved biological properties.  The present study examined the binding 
properties of six polyamide compounds, each with an attached alkyl side chain, with differing 
functional groups extending from the N5 position of the center heterocycle to the minor groove 
of the DNA sequence 5’-ACGCGT-3’.   
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Figure 5.1 Structures of the “parent” compound (f-ImPyIm), f-ImPy((CH2)3NH3)Im (1), f-
ImPy((CH2)3Cl)Im (2), f-ImPy((CH2)3N3)Im (3), f-ImPy((CH2)3alkyne)Im (4),  f-
ImPy((CH2)3NHAc)Im (5), and f-ImPy((CH2)3NHGly)Im (6). 
120 
 
 
 
Figure 5.2 SPR sensorgrams for the binding of f-ImPy((CH2)3NHGly)Im (6) to the sequence 5’-
ACGCGT-3’(A) and a plot of RUss vs concentration including a best-fit line (B).  The 
cooperative (K2 > K1) binding of two f-ImPy((CH2)3NHGly)Im molecules per 5’-ACGCGT-3’ is 
observed. 
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Figure 5.3  Experimental ITC data  (A) for the excess DNA method titration of polyamide 6 into 
5’-ACGCGT-3’ and the integrated heats for each injection of 6 used for the titration (red dots) 
and a linear fit (red line) of that data which is extrapolated to zero and yields of the ∆H reaction 
(B). 
A B 
∆H of binding 
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of compound 2 (f-ImPy((CH2)3CI)Im) on the antisense strand of  
∼500cps DNA fragment, 10 mM Tris, pH 7, 1 
2, 0.5 mM DTT, 20 mM HEPES. G + A denotes the 
-3’ site is indicated by a solid bar.  
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Figure 5.5 CD data for compound 6, (f-ImPy((CH2)3NHGly)Im), with the sequence 5’-
ACGCGT-3’. CD experiments were carried out using 160 µL of a 9 µM DNA solution, which 
was titrated with 1 mol equivalents of 6, past the point of saturation. The spectra represent 
titration from DNA alone to 1 mol equivalent of polyamide 6 to the DNA hairpin, 2, 3, 4, 5, 6, 8 
and 10 molar equivalents. 
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Table 5.1 Results for ITC and SPR experiments on polyamides 1-3, 5 and 6 with the sequence 
5’-ACGCGT-3’.  Included at the bottom are the thermodynamic properties and Keq value for the 
“parent” compound, f-ImPyIm, as where previously determined and from which these modified 
polyamides were derived. 
 
Polyamide 
 
 
∆Ha 
(kcal/mol) 
 
 
∆Gb 
(kcal/mol) 
 
T∆Sc 
(kcal/mol) 
 
Keq(M-1)b 
 
1 
 
-5.9 
 
-11.4 
 
5.5 
 
2.8 × 108 
 
2 -4.4 
 
-8.3 3.9 1.2× 106 
3 -4.5 -9.8 5.3 1.5× 106 
 
5 
 
-5.7 
 
-9.1 
 
3.4 
 
4.9 × 106 
 
6 
 
-4.5 
 
-10.6 
 
6.1 
 
6.2 × 107 
 
f-ImPyIm(5) 
 
 
-7.6 
 
-11.3 
 
3.7 
 
1.9 × 108 
 
Keq =   ; UD = unable to be determined due to insufficient heats from ITC experiments. aDetermined by 
ITC. bDetermined from SPR studies. c Calculated from the equation ∆S = (∆G-∆H)/T, using ∆G calculated from 
SPR and ∆H calculated from ITC. K values for polyamide 4 were unable to be determined by SPR because of 
surface problems.   
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Table 5.2 Results for thermal denaturation and DNase I footprinting experiments for polyamides 
1-6  and the parent compound f-ImPyIm from previously reported work. 
 
Polyamide 
   ∆Tm (°C) 
5’-ACGCGT-3’ 
 
5’-A3T3-3’ 
 
 
Footprinting 
(µM)a 
    
1 >24 10 0.05 
2 1.5 0 1 
3 4.8 0 1 
4 0 0 10 
5 10 1 0.1 
6 
f-ImPyIm (22) 
 
20 
7.3 
 
5 
NA 
 
0.5 
0.05 
 
NA- not available. aConcentration when footprint at the cognate site became apparent. 
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Table 5.3 Estimated half-lives (in hours) for the rate of dissociation of polyamides 1-3, 5 and 6 
from the sequence 5’-ACGCGT-3’. 
 
Polyamide 
 
~T1/2 (app*) (hr) 
1 >8.3 
2 0.22 
3 0.57 
5 2.6 
6 4.2 
* apparent half-lives based on dissociation rates from SPR 
experiments. 
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CHAPTER 6: 
PROMOTER SCANNING OF THE HUMAN COX-2 GENE WITH 8-RING 
POLYAMIDES: UNEXPECTED WEAKENING OF POLYAMIDE-DNA BINDING AND 
SELECTIVITY BY REPLACING AN INTERNAL N-Me-PYRROLE WITH β-ALANINE 
 
 
The work presented in this chapter is based on a submitted paper entitled “Promoter scanning of 
the COX-2 gene with 8-ring polyamides: Unexpected weakening of the polyamide-DNA binding 
and selectivity by replacing an internal N-Me-pyrrole with β-alanine”.  This paper has been 
submitted to Biochimie as of April of 2012.  Synthetic, fluorescence, and DNase footprinting 
methods, along with the corresponding written portions of this manuscript are ascribed to Dr. 
James K. Bashkin of the University of Missouri, St. Louis and his research group.  My 
contribution to this paper included the SPR experiments, data analyses and writings, with the 
combined efforts of Shuo Wang and Drs. Rupesh Nanjunda and W. David Wilson. 
 
 
 
 
 
129 
 
Promoter Scanning of the Human COX-2 Gene with 8-Ring 
Polyamides: unexpected weakening of polyamide-DNA Binding and 
selectivity by replacing and internal N-Me-Pyrrole with a β-alanine 
 
 
 
James K. Bashkin†, Karl Aston†, Joseph P. Ramos‡, Kevin J. Koeller†, Shuo Wang‡, Rupesh 
Nanjunda‡, Gaofei He†, Cynthia M. Dupureur†, and W. David Wilson‡ 
 
 
†Department of Chemistry & Biochemistry, Center for Nanoscience, University of Missouri-St. 
Louis, One University Blvd., St. Louis, MO 63121, USA  
 
‡Department of Chemistry, Georgia State University, Atlanta, GA 30302, USA 
 
 
 
 
 
 
 
 
 
 
130 
 
6.1 Abstract  
 Rules for polyamide DNA recognition have proved invaluable for the design of 
sequence-selective DNA-binding agents in cell-free systems.  However, these rules are not fully 
transferrable to predicting activity in cells, tissues or animals, and some refinements in 
understanding DNA recognition would help biomedical studies.  Similar complexities are 
encountered when using internal β-alanines as polyamide building blocks in place of N-methyl 
pyrrole; β-alanines were introduced in polyamide designs to maintain good hydrogen bonding 
registry with the target DNA, especially for long polyamides (P.B. Dervan, A.R. Urbach, Essays 
Contemp. Chem. (2001) 327-339).  Thus, to expand current rules, we compare the effects of 
replacing a single pyrrole with β-alanine in 8-ring polyamides.  Replacement of a single internal 
N-methylpyrrole with β-alanine in two 8-ring polyamides causes a decrease in DNA binding 
affinity by two orders of magnitude and decreases DNA binding selectivity, contrary to 
expectations.  Measurements were made by fluorescence spectroscopy, quantitative DNA 
footprinting and surface plasmon resonance, with these vastly different techniques showing 
excellent agreement.  Furthermore, results were validated for a range of DNA substrates from 
small hairpins to long dsDNA sequences.  These results combine with binding rules to refine 
design principles and expectations for polyamide-DNA recognition. 
 
Keywords:  Polyamide, DNA, fluorescence spectroscopy, surface plasmon resonance, 
footprinting, capillary electrophoresis.   
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6.2 Introduction 
N-methylpyrrole and -imidazole based polyamides (PA) are being used with increasing 
frequency in fundamental and applied biomedical research programs [1-4].  Although the field 
owes much to the work on lexitropsins and their analogs [5], most of the recent improvements in 
polyamide utility derive from the DNA recognition rules developed by Dervan [6].  These rules 
in principle allow one to build a polyamide that recognizes a DNA sequence of interest, for 
example in order to disrupt transcription factor-DNA binding as a means of controlling gene 
expression [7].  Dervan has also published extensively on refinements to the understanding of 
preferred and less-favored polyamide-DNA interactions [8-10].   
Even with this extensive knowledge at hand and the important additions to the field by 
Sugiyama, Laemmli, Lee and others [11-17], there is much that is unknown about PA design and 
modes of PA action in living cells.  For example, we have observed large variations in antiviral 
activity for polyamides that ostensibly bind the same DNA sites and are in some cases isomers of 
each other [18].  This work introduced a new approach to the use of polyamides: we did not try 
to disrupt transcription factor binding, but rather designed polyamides to bind protein/ DNA 
recognition sites such as those important for viral replication and maintenance of the double-
stranded viral DNA genome of high-risk, or cancer causing, human papillomavirus (HPV).  
Furthermore, we have found some complications in employing the process called promoter 
scanning [19]: the method can identify hotspots for DNA-PA interactions that lead to improved 
control of gene expression.  If these hotspots are near each other, it is tempting to construct 
larger PA molecules from the smaller species identified in the promoter scanning process in 
order to take advantage of improved DNA binding strength and selectivity.  This approach is 
particularly relevant in light of Sugiyama’s report that uptake of polyamides into some 
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mammalian cells can be effective and independent of MW over the range from 400 – 4,000 [11].  
Such results agree with our own observations that PAs with MWs well above 2000 show 
significant anti-HPV activity in human keratinocyte monolayers and in organotypic tissue culture 
[18].  However, we have not seen good correspondence between the activity of shorter 
polyamides and longer species prepared by combining short, active species.  One complication 
common to these matters is the question of how best to introduce β-alanine (β) groups [20] to act 
as the molecular springs necessary to keep good registry between the hydrogen bonding groups 
of DNA and polyamides as the length of polyamides increases. 
In order to better understand the incorporation of β in the construction of functional PAs 
from smaller molecules, we have carried out a systematic study of the role of β/N-methylpyrrole 
(Py) pairs vs. Py/Py pairs for DNA base pair recognition and binding.  The literature provides 
systematic studies of β/β pairs vs. Py/Py pairs [20, 21], but not as much information is available 
on any changes to DNA binding that might occur by replacing a single Py residue with β.  We 
report that, in contrast to the manner in which β helps maintain tight and selective DNA binding 
for some PA designs, especially when used as β/β pairs, β/Py pairs can greatly decrease the 
binding affinity and specificity of PA molecules for DNA. 
In order to validate our findings, we used orthogonal assay methods for measuring DNA 
binding thermodynamics and kinetics, including a fluorescence assay [22], Biacore using biotin-
labeled DNA hairpins [23-25], and quantitative footprinting [26].  We also studied a variety of 
DNA substrates from hairpins with 10 or 20 bp of duplex DNA to a linear, 120-mer dsDNA with 
one PA binding site and a 524-mer dsDNA with multiple PA binding sites.  Quantitative 
footprinting was done using fluorescent labels and capillary electrophoresis (CE) [27] rather than 
more traditional radiolabeling and PAGE methods.   
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6.3   Materials and Methods 
6.3.1   Synthesis   
Polyamides were prepared by solid phase synthesis using Boc methodology [28] and 
were characterized by HPLC/MS (ESI+), 1H NMR, high resolution mass spectrometry (ESI+ 
MSn) and combustion analysis.  Of note, isolation by RP-HPLC using mobile phases containing 
0.1%TFA led to all basic nitrogens being protonated, including imidazole. This contrasts with a 
previous report that used similar isolation procedures but indicated that imidazole groups were 
not protonated.  Elemental analysis for C, H, N and F has been vital to our characterization 
efforts and our determination of molecular formulae. 
6.3.2   Fluorescence Spectroscopy 
Changes in fluorescence intensity of a TAMRA-labeled, hairpin-forming 
oligonucleotide as a function of PA concentration were used to quantitate DNA binding [22].  
5’-CCT GGA GAG GAA GCC AAG TGT TTT CAC TTG GCT TCC TCT CCA GG-3’ was 
purchased from IDT HPLC pure (Coralville, IA) either unlabeled or labeled with T-TAMRA 
at either T34 or T37 as noted by the underlined T positions in the above sequence and as 
shown by asterisks in Figure 6.2.  Using a Centricon unit, the DNA was rinsed twice with 
Milli-Q water, subsequently annealed from boiling water, quantitated using the vendor 
extinction coefficient, and either aliquotted, lyophilized and stored at -20 °C or used directly. 
The experiments were performed using quartz cuvettes at 10 mM HEPES, 50 mM 
NaCl, 1 mM EDTA, pH 7.4, 25 °C on a Fluorolog-3 (SPEX) spectrofluorimeter.  All samples 
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were stirred continuously.  TAMRA-labeled oligonucleotides were excited at 559 nm and the 
resulting emission observed through a monochromator set at 580 nm or a 592 nm bandpass 
filter (Edmund Optics, Barrington, NJ).  Intensity values were obtained in triplicate and 
averaged and then normalized to fraction of bound DNA and then plotted against PA 
concentration.  Resulting data were fit to equation Eq. 1:  
 
                                              (Eq. 1) 
 
where Θ is fraction of bound duplex, [L] is the total concentration of PA, and Ka is the 
association constant. Kd values represent an average of at least three separate experiments.  
6.3.3   Competition Fluorescence Binding Assay   
Aliquots of unlabeled DNA hairpin PA were added to a solution of fluorescent DNA-PA 
complex at a concentration 10-fold above the Kd.  The resulting data were normalized and fit to a 
mathematical model describing both the labeled PA-DNA equilibrium (known Kd) and the 
unlabeled PA-DNA equilibrium (unknown Kd) using Scientist software (MicroMath, St. Louis, 
MO) as previously described [22].  
6.3.4   Surface Plasmon Resonance (SPR)   
Biosensor-SPR experiments were conducted with a BIAcore T100 or T200 instrument 
using similar procedures to those previously described [23, 25].  5’-Biotin labeled DNA hairpins 
were immobilized on streptavidin-linked sensor chips via non-covalent capture. The tight affinity 
Θ =
Ka[L]
1 + Ka[L]
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between biotin and streptavidin yields a highly stable surface over time, allowing for 
regeneration of DNA surfaces with relatively harsh conditions. Immobilization in each flow cell 
is performed independently in a separate cycle, so that different DNAs can be used in different 
flow cells. After washing the chip with 1 M NaCl/50 mM NaOH and buffer to remove unlinked 
streptavidin, a 50 nM solution of each DNA sequence was injected over a streptavidin 
derivatized flow cell until ~400 resonance units (RU) of the long DNA (complete) sequence (as 
shown in Figure 6.2) was immobilized and ~250 RU of shorter cognate and noncognate 
sequences were immobilized.   
Three flow cells contained DNA and one flow cell was left blank as a reference. For 
binding studies PA1-4 were diluted to different concentrations in degassed and filtered HEPES 
buffer (0.01 M HEPES and 0.001 M EDTA, 0.05 M NaCl, pH 7.4, and 0.05% surfactant P-20) 
and the diluted samples were injected over the DNA surface for a selected time. A 10 mM 
glycine solution at pH 2.5 was used for flow cell surface regeneration. Kinetics fits and steady-
state binding studies were carried out as previously described [23, 25].  Steady-state analysis was 
done by averaging the RU values (RU) in the plateau region of the sensorgrams over a selected 
time region at different compound concentrations. The binding constants were obtained from 
fitting plots of steady-state RU versus Cfree while kinetics fits were done in both the association 
and dissociation time regions [23, 25]. 
6.3.5   Quantitative DNase I Footprinting by Capillary Electrophoresis 
A 120 bp duplex was generated as described previously [22].  Its sequence is: 
Fam_ATGTGATAGGGTAGATGATGGAGGTGgagtttaatgaaatttctgcaagggtctgtaatatgttttgtaaattc
taa CCTGGAGAGGAAGCCAAGTG tttttggttacaaccattagcag.  The first sequence in capital 
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letters is from HPV16 2150-2175. The sequence in lower case letters originates from HPV16 
positions 2327-2377 and 2384-2406, which are the sequences surrounding the 5’-AAGCCA-3’ 
target site (bolded).  The underlined sequence is the same as the stem region of the DNA hairpin 
used for the above fluorescence studies and most SPR studies (i.e. the “long hairpin”).  To 
generate a 524 bp DNA fragment of the HPV16 genome containing three cognate sites for PA1 
and beginning at nt 2150, two oligomers were purchased from Integrated DNA Technologies, 
Inc. (Coralville, Iowa 52241).  The forward primer sequence is:  5’-Fam-ATG TGA TAG GGT 
AGA TGA TGG AGG TG; the reverse primer sequence is:  5’-G CTC ATA CAC TGG ATT 
TCC GTT TTC GTC ATA.  pUC19 with an HPV16 genome insert (Accession # AF125673) was 
used as the template.  PCR settings were 55 ºC/1 min annealing temperature, 68 ºC/min 
extension temperature/time with 33 cycles. The fragment was purified using a 2% agarose gel 
and purified with Qiagen gel extraction kit (Qiagen, Valencia, CA 91355).   
For footprinting [26], duplex DNA was mixed with polyamide in TKMC buffer (10 mM 
Tris, 10 mM KCl, 5 mM MgCl2 and 5 mM CaCl2), incubated at 37 ºC for time periods varying 
from 4 h to overnight.  PA concentrations as high as 60-80 nM were used to study weak binding 
sites.  Similar footprinting results were obtained for all these incubation times. The mixture was 
digested with RQ1 Rnase-Free DNase I (Promega, Madison, WI) for 5 min at 37 ºC and 
quenched by adding 30 µL of 500 mM EDTA.  The DNase I digested product was purified with 
Qiagen PCR purification kit (Qiagen, Valencia, CA) and eluted with 30 µL of buffer.  A few µL 
of the resulting samples were analyzed using an ABI 3100 Capillary Electrophoresis sequencer 
(Carlsbad, California).  Data were processed using Genemarker V1.97 software (Softgenetics 
LLC, State College, PA).  Peaks in the footprint were normalized to a neighboring peak not 
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sensitive to PA concentration, plotted as fraction bound vs. PA concentration, and fit to the 
Langmuir isotherm as described above.   
6.4   Results 
6.4.1   Polyamide and DNA Target Design 
To carry out the comparative biophysical studies of the effects on DNA binding of β/Py 
replacements at internal positions of eight-ring polyamides, we prepared the compound pairs 
shown in Figure 6.1.  The resulting compounds all target part of the human COX-2 Ets-1 binding 
site [29-31].  
Compounds PA1-4 comprise two isomer pairs (PA1/PA2 and PA3/PA4) that differ only 
by replacement of an internal Py building block by β-alanine.  All four compounds were 
designed to recognize the same sequence, but they bind in different orientations, as shown in 
Figure 6.2. The essentially identical DNA hairpins used in this study are based on the human 
COX-2 promoter in the Ets-1 binding region: the only difference is the location of a TAMRA 
dye for fluorescence studies, at T37 for PA1-2 and at T34 for PA3-4.  These hairpins were used in 
the present study as (a) dye derivatives, (b) unfunctionalized DNA and (c) 5’-biotin conjugates in 
order to measure DNA-PA dissociation constants and kinetic parameters of PA1-4 binding their 
cognate DNA sites.  In addition, the binding of PA1 and PA2 was studied by quantitative 
footprinting on a linear 120-bp DNA duplex.  PA1 binding to a 524-bp DNA sequence with 
several cognate and noncognate (single bp mismatch) sites was also examined by quantitative 
footprinting, and SPR was performed on a noncognate hairpin treated with PA3 (see below). 
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6.4.2   Fluorescence Spectroscopy 
Isotherms were observed using relatively large and easily reproducible decreases in 
TAMRA fluorescence intensity upon PA binding (10-50% depending on PA and dye location).  
Binding isotherms for PA2-4 are shown in Figure 6.3ABC (for the isotherm of PA1, see Ref. 
[22]).  Unlabeled DNA was used in competition with dye-labeled DNA to evaluate potential dye-
related artifacts (Figure 6. 3D; Ref. [22]); dyes were found not to interfere with interpretation 
(Table 6.1).  Using this technique, we found that Kd values of ≤1 nM increased by ca. 100-fold 
when a single Py in PA1 was replaced by β to give PA2, and a similar increase in Kd occurred 
when a single internal Py was replaced in PA3 to give PA4. 
6.4.3   Surface Plasmon Resonance 
Using surface plasmon resonance, striking differences in behavior of PAs with and 
without an internal β residue are also easily seen in Figure 6.4AB, which features SPR 
sensorgrams for PA1 and PA2 binding to the cognate DNA sequence in Figure 6.2.  The 
concentrations required to saturate the binding sites in PA1 are well below those required for 
PA2.  Further, the kinetics, particularly for dissociation, are much slower for PA1 than PA2 
(Table 6.1). PA3 binds even more strongly than PA1 to the same DNA hairpin; sensorgrams for 
PA3 binding are shown in Figure 6.4C.  The sensorgrams for PA4 are very similar to those for 
PA2 and are not shown.  The sensorgrams for PA1 and PA3 do not reach a steady-state plateau 
until almost saturation binding and were fit with a single-binding site kinetic model to determine 
both kinetics and equilibrium constants for binding [23-25].  As can be seen in the figures, the 
fits are excellent.  The kinetics for PA2 and PA4 with DNA are too fast to fit with a kinetic 
model, but since they reach a steady-state, they were fit by using the steady-state RU values and 
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a single binding site model [23-25].  In this case, the fits are also excellent (not shown) and the 
results are in Table 6.1.  These results clearly illustrate the detrimental effects of β-alanine 
substitution for DNA binding with these PAs, conditions and DNA sequences.  The fact that no 
binding was detected by SPR between PA3 and a noncognate, single-bp mismatch DNA hairpin 
(Figure 6.4D) provides additional support for the highly selective DNA binding of PA1 and PA3, 
compounds lacking internal β residues.   
At concentrations of 10 nM and higher, all four PAs bind rapidly to DNA in SPR 
experiments and reach a steady state plateau.  The dissociation rate constants, however, are much 
smaller for PA1 and PA3 than for PA2 and PA4. This observation suggests that all of the 
polyamides rapidly locate their DNA binding sites and associate with the minor groove. Once 
bound, however, PA1 and PA3 form exceptionally tight complexes that dissociate very slowly 
from DNA. In these cases, in contrast to the systems mentioned above, the flexible β linker 
prevents tight binding of PAs in comparison to equivalently substituted pyrrole derivatives.  
Furthermore, the more rigid species PA1 and PA3 show excellent discrimination against single-
base pair mismatches (Figure 6.3CD), again in contrast to prior reports of similar molecules [32].  
Table 6.1 illustrates the excellent agreement found between fluorescence and SPR measurements 
for both the tight binding PA1 and PA3 and the weaker-binding PA2 and PA4, providing 
validation for both experimental approaches. 
6.4.4   Quantitative DNase I Footprinting 
To compare single site binding affinities of PA1 and PA2 for a linear dsDNA molecule 
larger than the above DNA hairpins, a 120 bp duplex with a single PA1/2 binding site was 
generated.  The central part of the sequence is identical to the stem portion of the above hairpin 
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used for fluorescence and SPR studies (see Section 2.5).  The flanking sequences were derived 
from a portion of the HPV16 genome that we predicted to contain no additional binding sites for 
PA1 or PA2.  Quantitative DNase I footprinting on this duplex yields Kds of 1.1 ± 0.2 nM [22] 
and 80 ± 8 nM for PA1 and PA2, respectively.  These data agree remarkably well with the results 
obtained by other methods, providing additional evidence that Kds obtained with the relatively 
small DNA hairpins are indicative of affinities observed in larger DNA contexts.   
To determine how PA1 binds its target in an even larger sequence context, we studied 
PA1 binding to an AT-rich 524 bp duplex from the HPV16 genome using DNase I footprinting 
and capillary electrophoresis [27, 33].  As summarized in Table 6.2 and illustrated in Figure 6.5, 
PA1 binds to three cognate sites with high affinity.  This provides further confirmation of the 
aforementioned observations involving a small DNA hairpin, and indicates that PA1 binds its 
target avidly and specifically within the larger context of a long DNA sequence.  Binding at 
single bp mismatch sites in the 524-mer was so weak as to be largely unobserved at [PA] ≤ 60 
nM, with resulting noncognate Kd values conservatively estimated at ≥ 60-100 nM.   
While anomalies in DNA binding of β-substituted polyamides have been mentioned [20, 
21], no quantitative details of such behavior have been previously reported to our knowledge.  
Instead of finding improved binding strength and specificity upon incorporating β for Py in an 8-
ring polyamide [32], we found the opposite. The binding results reported here took on additional 
significance for us because of our use of PA molecules as anti-human papillomavirus (HPV) 
agents in collaboration with NanoVir, LLC.  Screening libraries of compounds with internal β/Py 
substitutions shuffled throughout the sequence targets the same cognate binding site, but 
produces both active and inactive anti-HPV compounds [18, 34].  The present report helps guide 
future PA design and structure-activity studies for our own and other labs. In particular, the 
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effect of incorporating β-alanine into PA designs is not straightforward, and the standard binding 
rules can be insufficient to predict DNA binding strength or selectivity.  The same may hold true 
for predicting polyamide activity in cells, tissue culture and whole animals, and this hypothesis is 
under current investigation.  
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Figure 6.1  Structures of compounds PA1-PA4. They are shown as monocations for clarity; they 
are isolated as tetracations. Bold bonds indicate the Py and β pairs compared in this study. 
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Figure 6.2  Map of predicted polyamide-DNA interactions: (A) PA1/2 and (B) PA3/PA4 bound 
to hairpin DNA.  Open circle: Py; filled circle: Im; open diamond: β; filled diamond: Py (PA1, 
PA3) or β (PA2, PA4); (+: Dp; curved line: γ; *: position of TAMRA dye when used.  A 5’-
Biotin conjugate of the DNA without dye labels was used for SPR. 
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Figure 6.3 Polyamide-DNA binding as observed via fluorescence spectroscopy.   Binding 
isotherms for PA2 (A), PA3 (B), and PA4 (C) toward TAMRA-labeled DNA hairpin as 
described in the text.  (D) Sample competition experiment between an unlabeled DNA hairpin 
and a labeled DNA hairpin bound to PA2.  Conditions:  10 mM HEPES, 50 mM NaCl, 1 mM 
EDTA, pH 7.4, 25 °C.   
148 
 
 
Figure 6.4 Polyamide-DNA Binding as observed via SPR. Sensorgrams for the interactions of 
PA1 (A) and PA2 (B) with the hairpin DNA shown in Figure 6.2 labeled with 5’-biotin.  
Individual sensorgrams represent responses at different PA concentrations: concentrations for 
PA1 are 1.0, 1.5, 2.0, 2.5, 3.0, 5.0 and 10.0 nM; concentrations for PA2 are 1.0, 10, 20, 40, 60, 
100, 200 and 400 nM. (C) Sensorgram for the interactions of PA3 with the cognate hairpin DNA 
from Figure 6.2  (D) the noncognate hairpin DNA, sequence 5’-Biotin-
CCTTGGAGAGTTTTCTCTCCAAGG-3’, with the hairpin loop underlined.  The individual 
sensorgrams represent responses at different PA concentrations. The concentrations for PA3 are 
1.0, 2.0, 4.0, 6.0 and 8.0 nM in both panels. Kinetic and steady-state fits used BIAcore T100 
Evaluation Software.    
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Figure 6.5  PA1-DNA Binding via Quantitative Footprinting and CE. Sample isotherm of PA1 
binding an AT rich 524 DNA duplex as detected by DNase I footprinting and capillary 
electrophoresis; conditions: 0.2 nM duplex; otherwise as per text.  Data fit to a Kd of 1.6 nM. 
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Table 6.1 Data for DNA binding of PA1-PA4 to DNA hairpin by fluorescence (FL) and SPR.  
 
Cmpd. Sequence Kd/FL 
(nM)a 
Kd/FL 
competition 
(nM )b 
Kd/SPR 
(nM) 
ka/SPR 
(M-1s-1) 
kd/SPR 
(s-1) 
 
PA1 
 
 
dImImPyPyγPyImPyPyβDp 
 
2.3 ± 0.3d 1.1 ± 0.2d 
 
 
1.12 ± 0.21 
 
5.3 × 107 
 
0.059 
 
PA2 dImImβPyγPyImPyPyβDp 170 ± 40 325 ± 150 
 
83.4 ± 8.9 tfc tf 
 
PA3 dImPyPyPyγPyImImPyβDp 11.0 ± 1.0d ≤ 1.0 
 
0.71 ± 0.14 1.2 × 107 0.0085 
 
PA4 dImβPyPyγPyImImPyβDp 120 ± 15 70 ± 30 
 
106 ± 11 tf tf 
 
aC-5 TAMRA dye substitution at T37 for PA1-2 and T34 for PA3-4. bFrom competition of 
unlabeled DNA with dye-labeled DNA. ctf: too fast to determine, most of the interaction occurs 
during filling of the flow cells and the dissociation occurs during filling with buffer. 
dReproduced from Ref. [22] 
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Table 6.2. Sites and Kd values for PA1 bound to a 524 bp DNAa.     
    
 
 
 
 
 
 
 
 
 
Polyamide binding site 
 
Kd (nM) 
 
5’-AGGCAT-3’ 1.6±0.2  
5’-AAGCCA-3’ 3.3±1  
5’-ATGCCA-3’ 2.6±1  
5’-AGGTAT-3’ 60-100  
5’-AGGTAA-3’ >100  
5’-TGGCCT-3’ (two sites) 
>60  
aDetermined by quantitative DNase I 
footprinting; mismatches in bold. 
 
 
 
152 
 
 
